Subscribe

Agilent Technologies, Inc. (A)

USD134.66 +0.62 (+0.46%)
US NYSE S&P 500 Healthcare Medical - Diagnostics & Research
Address 5301 Stevens Creek Boulevard 95051
Santa Clara, CA, US
CEO Padraig McDonnell
IPO 1999-11-18
CIK 1090872 ISIN US00846U1016

Explore sections of this company profile

Also trades on London Stock Exchange · 0HAV.L (USD) New York Stock Exchange · A (USD)
Description

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Index membership

IndexAddedRemovedStatus
S&P 500 2000-06-02 Active
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD134.66 +0.62 (+0.46%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.26
Float Shares
281.66M
Free Float %
99.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.65% +0.70% +0.18% -4.57% -24.54% -14.87% +4.11% -1.61% -15.78% +152.79% +302.19%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (38 ratings, all time) Buy
Price Targets & DCF
Current price
134.66
Low 140.00 +4.0%
Consensus 161.13 +19.7%
Median 158.00 +17.3%
High 180.00 +33.7%
DCF (Unlevered) 79.81 -40.7%
DCF (Levered) 78.72 -41.5%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 79% Bullish
Rating 2026-05 Change
Strong Buy 5 +1
Buy 10 0
Hold 4 -1
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month 2
154.50
+14.7%
Last Quarter 4
149.75
+11.2%
Last Year 19
164.79
+22.4%
All Time 37
155.95
+15.8%
Quality scores
Altman Z-Score
4.67
Safe zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
7 / 10
Strong MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers ★ Strong MOAT
  • Revenue growth Medical - Diagnostics & Research: +7.9%
    +6.7% Q2'26: +10.0% (vs Q2'25)
  • EPS growth Medical - Diagnostics & Research: +30.8%
    +3.2% Q2'26: +60.0% (vs Q2'25)
  • FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%
    +17.9% Q2'26: +20.2% (vs Q2'25)
  • EBIT margin Medical - Diagnostics & Research: +9.6%
    +22.3% Q2'26: +0.0% (vs Q2'25)
  • ROIC Medical - Diagnostics & Research: +5.2%
    +16.9% Q2'26: +0.0% (vs Q2'25)
  • Share dilution Medical - Diagnostics & Research: 0.0%
    -2.4% Q2'26: -0.4% (vs Q2'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×
    1.83× Q2'26: 3.15× (vs Q2'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.22) × ERP
WACC = 91% × Ke + 9% × Kd (4.2%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 80.11 Current price: 134.66
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Oct 2011
actual
Oct 2012
actual
Oct 2013
actual
Oct 2014
actual
Oct 2015
actual
Oct 2016
actual
Oct 2017
actual
Oct 2018
actual
Oct 2019
actual
Oct 2020
actual
Oct 2021
actual
Oct 2022
actual
Oct 2023
actual
Oct 2024
actual
Oct 2025
actual
Oct 2026
12 Rev. Ana.
11 EPS Ana.
Oct 2027
13 Rev. Ana.
11 EPS Ana.
Oct 2028
12 Rev. Ana.
5 EPS Ana.
Oct 2029
6 Rev. Ana.
1 EPS Ana.
Oct 2030
7 Rev. Ana.
1 EPS Ana.
Revenue
6.62B
est: 6.19B (+6.9%)
6.86B
est: 6.71B (+2.2%)
3.89B
est: 5.90B (-34.0%)
4.05B
est: 4.01B (+1.0%)
4.04B
est: 4.04B (0.0%)
4.20B
est: 4.16B (+1.0%)
4.47B
est: 4.45B (+0.4%)
4.91B
est: 4.88B (+0.8%)
5.16B
est: 5.13B (+0.7%)
5.34B
est: 5.26B (+1.6%)
6.32B
est: 6.32B (+0.0%)
6.85B
est: 6.76B (+1.3%)
6.83B
est: 6.82B (+0.2%)
6.51B
est: 6.48B (+0.4%)
6.95B
est: 6.92B (+0.4%)
7.39B
7.35B – 7.42B
+6.9% YoY
7.84B
7.76B – 7.90B
+6.1% YoY
8.36B
8.36B – 8.36B
+6.6% YoY
8.82B
8.74B – 8.87B
+5.4% YoY
9.32B
9.23B – 9.38B
+5.7% YoY
EBITDA
1.37B
est: 1.27B (+7.6%)
1.45B
est: 1.41B (+2.7%)
758.00M
est: 1.25B (-39.5%)
723.00M
est: 1.46B (-50.4%)
799.00M
est: 946.66M (-15.6%)
863.00M
est: 1.04B (-17.4%)
1.10B
est: 1.08B (+1.7%)
1.23B
est: 1.94B (-36.6%)
1.23B
est: 1.39B (-11.6%)
1.23B
est: 1.46B (-15.6%)
1.76B
est: 1.73B (+2.1%)
1.91B
est: 1.85B (+2.8%)
1.70B
est: 2.04B (-16.5%)
1.87B
est: 1.76B (+6.4%)
1.84B
est: 1.88B (-2.4%)
2.01B
2.00B – 2.02B
+6.9% YoY
2.13B
2.11B – 2.15B
+6.1% YoY
2.27B
2.27B – 2.27B
+6.6% YoY
2.39B
2.37B – 2.41B
+5.4% YoY
2.53B
2.51B – 2.55B
+5.7% YoY
EBIT
1.12B
est: 996.07M (+12.2%)
1.14B
est: 1.09B (+4.9%)
386.00M
est: 890.58M (-56.7%)
339.00M
est: 1.08B (-68.5%)
546.00M
est: 646.37M (-15.5%)
616.00M
est: 746.09M (-17.4%)
882.00M
est: 829.28M (+6.4%)
1.02B
est: 1.49B (-31.5%)
993.00M
est: 1.06B (-6.6%)
920.00M
est: 996.15M (-7.6%)
1.44B
est: 1.32B (+9.2%)
1.59B
est: 1.47B (+7.9%)
1.43B
est: 1.62B (-11.4%)
1.62B
est: 1.48B (+9.4%)
1.55B
est: 1.58B (-2.0%)
1.69B
1.68B – 1.69B
+6.9% YoY
1.79B
1.77B – 1.80B
+6.1% YoY
1.91B
1.91B – 1.91B
+6.6% YoY
2.01B
1.99B – 2.02B
+5.4% YoY
2.12B
2.11B – 2.14B
+5.7% YoY
Net Income
1.01B
est: 945.36M (+7.0%)
1.15B
est: 1.12B (+3.4%)
724.00M
est: 679.77M (+6.5%)
549.00M
est: 596.45M (-8.0%)
401.00M
est: 491.46M (-18.4%)
460.00M
est: 561.03M (-18.0%)
684.00M
est: 672.36M (+1.7%)
316.00M
est: -438.87M (+172.0%)
1.07B
est: 1.14B (-6.2%)
719.00M
est: 846.92M (-15.1%)
1.21B
est: 1.18B (+2.5%)
1.25B
est: 1.28B (-1.7%)
1.24B
est: 1.24B (-0.2%)
1.29B
est: 1.49B (-13.4%)
1.30B
est: 1.58B (-17.7%)
1.69B
1.68B – 1.70B
+6.9% YoY
1.86B
1.83B – 1.90B
+10.1% YoY
2.06B
1.93B – 2.20B
+10.8% YoY
2.28B
2.25B – 2.30B
+10.5% YoY
2.47B
2.44B – 2.49B
+8.1% YoY
SGA
1.81B
est: 1.68B (+7.7%)
1.82B
est: 1.77B (+2.5%)
1.88B
est: 1.76B (+6.7%)
2.04B
est: 2.71B (-24.5%)
1.19B
est: 1.49B (-20.3%)
1.25B
est: 1.52B (-17.7%)
1.23B
est: 1.21B (+1.6%)
1.37B
est: 2.17B (-36.8%)
1.46B
est: 1.66B (-11.9%)
1.50B
est: 1.79B (-16.4%)
1.62B
est: 1.60B (+1.3%)
1.64B
est: 1.60B (+2.6%)
1.63B
est: 1.76B (-6.9%)
1.52B
est: 1.57B (-3.5%)
1.71B
est: 1.68B (+1.8%)
1.79B
1.78B – 1.80B
+6.9% YoY
1.90B
1.88B – 1.92B
+6.1% YoY
2.03B
2.03B – 2.03B
+6.6% YoY
2.14B
2.12B – 2.15B
+5.4% YoY
2.26B
2.24B – 2.28B
+5.7% YoY
EPS
2.92
est: 2.57 (+13.6%)
3.31
est: 2.98 (+11.1%)
2.12
est: 2.55 (-16.9%)
1.65
est: 4.07 (-59.4%)
1.20
est: 1.71 (-29.7%)
1.42
est: 1.91 (-25.6%)
2.12
est: 2.32 (-8.5%)
0.98
est: 2.72 (-63.9%)
3.41
est: 3.08 (+10.6%)
2.33
est: 3.24 (-28.1%)
3.98
est: 4.31 (-7.7%)
4.19
est: 5.07 (-17.4%)
4.22
est: 5.41 (-22.0%)
4.44
est: 5.24 (-15.3%)
4.59
est: 5.57 (-17.6%)
5.97
5.92 – 6.00
+7.1% YoY
6.55
6.44 – 6.68
+9.7% YoY
7.27
6.79 – 7.75
+11.1% YoY
8.03
7.94 – 8.10
+10.4% YoY
8.68
8.58 – 8.75
+8.1% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-05-26 Baird Outperform Outperform Maintain
2026-04-28 Keybanc Sector Weight Sector Weight Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-27 B+ 3/5 4/5 5/5 5/5 2/5 1/5 1/5
2026-05-26 B+ 3/5 4/5 5/5 5/5 2/5 1/5 1/5
2026-05-22 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-21 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-20 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-19 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-18 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-15 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-14 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-13 B+ 3/5 3/5 5/5 5/5 2/5 2/5 1/5
2026-05-12 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-11 A- 4/5 4/5 5/5 5/5 2/5 2/5 2/5
2026-05-08 B+ 3/5 3/5 5/5 5/5 2/5 2/5 2/5
2026-05-07 B+ 3/5 3/5 5/5 5/5 2/5 2/5 2/5
2026-05-06 B+ 3/5 3/5 5/5 5/5 2/5 2/5 2/5
2026-05-05 B+ 3/5 3/5 5/5 5/5 2/5 2/5 1/5
2026-05-04 B+ 3/5 3/5 5/5 5/5 2/5 2/5 1/5
2026-05-01 B 3/5 3/5 5/5 5/5 1/5 2/5 1/5
2026-04-30 B 3/5 3/5 5/5 5/5 1/5 2/5 1/5
2026-04-29 B 3/5 3/5 5/5 5/5 1/5 2/5 1/5
2026-04-28 B 3/5 3/5 5/5 5/5 1/5 2/5 1/5
2026-04-27 B+ 3/5 3/5 5/5 5/5 1/5 2/5 2/5
2026-04-24 B+ 3/5 3/5 5/5 5/5 1/5 2/5 2/5
2026-04-23 B+ 3/5 3/5 5/5 5/5 1/5 2/5 2/5
2026-04-22 B+ 3/5 3/5 5/5 5/5 1/5 2/5 2/5
2026-04-21 B 3/5 3/5 4/5 5/5 1/5 2/5 2/5
2026-04-20 B 3/5 3/5 4/5 5/5 1/5 2/5 2/5
2026-04-17 B+ 3/5 4/5 4/5 5/5 1/5 2/5 2/5
2026-04-16 B+ 3/5 4/5 4/5 5/5 1/5 2/5 2/5
2026-04-15 B+ 3/5 4/5 4/5 5/5 1/5 2/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
1.38B
OE per share TTM
4.87
Owner's Yield
4.21%
Maintenance CapEx ratio
37.68%
Maint CapEx / Avg PPE
20.8%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
1,096
Total invested
28.94B
Insider transactions (90d)
3
Beneficial owners (>5%)
15
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 FMR Corp. 32.77M 8.05% 4.26M 32.77M HC Delaware 2007-02-14
2 (1) BlackRock, Inc. 30.08M 10.00% 25.90M 30.08M HC Delaware 2022-04-08
3 Davis Selected Advisers, L.P. 28.23M 8.09% 22.40M 22.40M IA Colorado 2010-02-12
4 The Vanguard Group - 23-1945930 24.27M 8.04% 23.01M 1.26M IA Pennsylvania 2022-02-09
5 943112180 23.43M 4.65% 19.78M 23.43M BK U.S.A. 2006-01-26
6 Abigail P. Johnson 23.19M 6.92% 23.19M IN United States of America 2015-02-13
7 Edward C. Johnson 3d 23.19M 6.92% 23.19M IN United States of America 2015-02-13
8 52-0556948 21.69M 7.10% 8.60M IA Maryland 2022-02-14
9 BlackRock for purposes of Schedule 13G filings. 19.85M 5.69% 19.85M 19.85M HC Delaware 2010-01-29
10 Identification #52-2069785 (formerly 13-2631108) 16.74M 11.00% 10.27M 16.74M IA Delaware 2012-02-10
11 04-2747644 15.59M 5.40% 15.13M 15.59M IA Delaware 2024-11-12
12 77-0518772 13.14M 56.60% 13.14M 10.00 CO State of Delaware 2007-04-16
13 BARCLAYS GLOBAL INVESTORS, LTD 3.30M 0.66% 3.05M 3.30M BK England 2006-01-26
14 BARCLAYS GLOBAL FUND ADVISORS 2.51M 0.50% 2.46M 2.51M IA U.S.A. 2006-01-26
15 BARCLAYS GLOBAL INVESTORS JAPAN TRUST AND BANKING COMPANY LIMITED 385.5K 0.08% 385.5K 385.5K BK Japan 2006-01-26

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
1,096
-80 vs prev Q
New positions
107
Closed positions
186
Increased
505
Reduced
373
Put/Call ratio
1.09
Calls held
656.9K
Puts held
714.3K
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 VANGUARD GROUP INC 34.11M +67.1K (+0.2%) 4.64B +271.9M (+6.2%) 12.05% +0.024 pp 0.07% +0.002 pp USD67.12 +102.7% 84 qtrs
2 BLACKROCK, INC. 25.87M -276.0K (-1.1%) 3.52B +164.3M (+4.9%) 9.14% -0.098 pp 0.06% +0.001 pp USD148.22 -8.2% 6 qtrs
3 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 14.15M +1.7M (+13.8%) 1.93B +329.1M (+20.6%) 5.00% +0.605 pp 0.62% +0.126 pp USD127.34 +6.9% 24 qtrs
4 STATE STREET CORP 12.68M +241.0K (+1.9%) 1.73B +125.8M (+7.9%) 4.48% +0.085 pp 0.06% +0.002 pp USD48.60 +180.0% 51 qtrs
5 T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 8.14M -4.2K (-0.1%) 1.11B +62.3M (+6.0%) 2.88% -0.002 pp 0.70% +0.060 pp USD121.15 +12.3% 14 qtrs
6 WELLINGTON MANAGEMENT GROUP LLP 7.59M -1.8M (-19.1%) 1.03B -171.2M (-14.2%) 2.68% -0.633 pp 0.18% -0.030 pp USD111.53 +22.0% 61 qtrs
7 GEODE CAPITAL MANAGEMENT, LLC 7.43M +25.1K (+0.3%) 1.01B +60.5M (+6.4%) 2.62% +0.009 pp 0.06% +0.002 pp USD76.26 +78.4% 78 qtrs
8 DEUTSCHE BANK AG\ 5.55M -29.3K (-0.5%) 754.93M +39.1M (+5.5%) 1.96% -0.010 pp 0.25% +0.006 pp USD102.23 +33.1% 50 qtrs
9 MORGAN STANLEY 5.04M +692.2K (+15.9%) 686.05M +127.8M (+22.9%) 1.78% +0.245 pp 0.04% +0.007 pp USD126.92 +7.2% 51 qtrs
10 PICTET ASSET MANAGEMENT HOLDING SA 4.66M -593.3K (-11.3%) 634.77M -40.1M (-5.9%) 1.65% -0.210 pp 0.62% -0.034 pp USD113.76 +19.6% 10 qtrs
11 GENERATION INVESTMENT MANAGEMENT LLP 4.18M -2.2M (-34.3%) 568.81M -247.2M (-30.3%) 1.48% -0.770 pp 3.95% -1.461 pp USD136.25 -0.1% 6 qtrs
12 NORGES BANK 4.04M +4.0M (+100.0%) 549.16M +549.2M (+100.0%) 1.43% +1.426 pp 0.06% +0.059 pp USD136.07 +0.0% 1 qtrs NEW
13 STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 3.83M +— (+0.0%) 520.51M +29.5M (+6.0%) 1.35% +0.000 pp 0.41% -0.001 pp USD49.52 +174.8% 103 qtrs
14 NORTHERN TRUST CORP 3.79M -88.6K (-2.3%) 515.29M +17.9M (+3.6%) 1.34% -0.031 pp 0.07% +0.002 pp USD68.90 +97.5% 51 qtrs
15 CANTILLON CAPITAL MANAGEMENT LLC 3.12M +23.5K (+0.8%) 423.94M +27.1M (+6.8%) 1.10% +0.008 pp 2.29% +0.107 pp USD59.78 +127.6% 41 qtrs
16 GOLDMAN SACHS GROUP INC 3.08M +555.3K (+22.0%) 419.72M +95.1M (+29.3%) 1.09% +0.196 pp 0.05% +0.012 pp USD127.20 +7.0% 73 qtrs
17 BANK OF NEW YORK MELLON CORP 2.86M +845.7K (+42.0%) 388.86M +130.6M (+50.6%) 1.01% +0.299 pp 0.07% +0.019 pp USD75.39 +80.5% 66 qtrs
18 IMPAX ASSET MANAGEMENT GROUP PLC 2.60M -366.2K (-12.4%) 353.18M -27.0M (-7.1%) 0.92% -0.129 pp 2.21% -0.009 pp USD103.99 +30.8% 30 qtrs
19 INVESCO LTD. 2.59M +627.8K (+32.0%) 352.52M +100.6M (+39.9%) 0.92% +0.222 pp 0.05% +0.014 pp USD118.73 +14.6% 57 qtrs
20 UBS ASSET MANAGEMENT AMERICAS INC 2.54M -476.4K (-15.8%) 345.11M -41.6M (-10.7%) 0.90% -0.168 pp 0.07% -0.011 pp USD104.74 +29.9% 90 qtrs
21 TROY ASSET MANAGEMENT LTD 2.41M +1.7K (+0.1%) 327.37M +18.8M (+6.1%) 0.85% +0.001 pp 8.44% +0.514 pp USD106.12 +28.2% 25 qtrs
22 JPMORGAN CHASE & CO 2.28M +18.9K (+0.8%) 309.67M +20.0M (+6.9%) 0.80% +0.007 pp 0.02% +0.002 pp USD126.84 +7.3% 51 qtrs
23 AMERIPRISE FINANCIAL INC 2.19M -513.6K (-19.0%) 298.67M -49.0M (-14.1%) 0.78% -0.182 pp 0.07% -0.012 pp USD121.22 +12.3% 55 qtrs
24 LEGAL & GENERAL GROUP PLC 2.14M -48.5K (-2.2%) 291.35M +10.3M (+3.7%) 0.76% -0.017 pp 0.06% +0.002 pp USD69.67 +95.3% 75 qtrs
25 QUBE RESEARCH & TECHNOLOGIES LTD 2.12M +1.3M (+169.7%) 288.58M +187.6M (+185.9%) 0.75% +0.472 pp 0.29% +0.189 pp USD129.78 +4.8% 23 qtrs
26 WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.06M -81.1K (-3.8%) 280.71M +5.5M (+2.0%) 0.73% -0.029 pp 0.78% +0.071 pp USD136.22 -0.1% 31 qtrs
27 DIMENSIONAL FUND ADVISORS LP 1.92M +115.2K (+6.4%) 261.76M +29.7M (+12.8%) 0.68% +0.041 pp 0.05% +0.005 pp USD97.62 +39.4% 51 qtrs
28 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.82M +27.0K (+1.5%) 247.78M +17.5M (+7.6%) 0.64% +0.010 pp 0.04% +0.002 pp USD69.80 +94.9% 100 qtrs
29 NORDEA INVESTMENT MANAGEMENT AB 1.77M -106.3K (-5.7%) 242.98M +7.5M (+3.2%) 0.63% -0.038 pp 0.21% +0.002 pp USD132.00 +3.1% 88 qtrs
30 VAN ECK ASSOCIATES CORP 1.61M -1.4M (-46.4%) 219.43M -166.6M (-43.2%) 0.57% -0.493 pp 0.18% -0.177 pp USD120.52 +12.9% 32 qtrs
31 BALYASNY ASSET MANAGEMENT L.P. 1.41M +928.8K (+192.0%) 192.20M +130.1M (+209.6%) 0.50% +0.328 pp 0.24% +0.165 pp USD133.44 +2.0% 7 qtrs
32 BANK OF AMERICA CORP /DE/ 1.37M +150.9K (+12.4%) 186.66M +30.0M (+19.1%) 0.48% +0.053 pp 0.01% +0.003 pp USD104.51 +30.2% 52 qtrs
33 AQR CAPITAL MANAGEMENT LLC 1.37M -312.1K (-18.6%) 186.14M -23.2M (-11.1%) 0.48% -0.110 pp 0.10% -0.037 pp USD120.09 +13.3% 63 qtrs
34 PRIMECAP MANAGEMENT CO/CA/ 1.34M -75.3K (-5.3%) 181.98M +664.1K (+0.4%) 0.47% -0.027 pp 0.14% -0.001 pp USD41.60 +227.1% 93 qtrs
35 DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN 1.19M +776.8K (+187.0%) 162.22M +108.9M (+204.3%) 0.42% +0.275 pp 0.14% +0.093 pp USD133.64 +1.8% 25 qtrs
36 FMR LLC 1.15M +33.3K (+3.0%) 156.69M +13.2M (+9.2%) 0.41% +0.012 pp 0.01% +0.001 pp USD134.92 +0.9% 70 qtrs
37 FRANKLIN RESOURCES INC 1.12M -24.3K (-2.1%) 151.82M +5.5M (+3.8%) 0.39% -0.009 pp 0.04% +0.001 pp USD75.53 +80.2% 51 qtrs
38 TD ASSET MANAGEMENT INC 1.05M -51.5K (-4.7%) 143.39M +1.5M (+1.1%) 0.37% -0.018 pp 0.12% +0.000 pp USD107.55 +26.5% 51 qtrs
39 ROBECO SCHWEIZ AG 1.05M -115.8K (-9.9%) 142.75M -6.8M (-4.5%) 0.37% -0.041 pp 3.20% -0.163 pp USD103.27 +31.8% 45 qtrs
40 CCLA INVESTMENT MANAGEMENT 1.05M +19.5K (+1.9%) 142.54M +10.6M (+8.1%) 0.37% +0.007 pp 2.29% +0.177 pp USD122.50 +11.1% 14 qtrs
41 MACKENZIE FINANCIAL CORP 1.02M +84.6K (+9.0%) 140.55M +20.1M (+16.7%) 0.36% +0.030 pp 0.17% +0.021 pp USD125.40 +8.5% 29 qtrs
42 AMUNDI 1.01M -12.3K (-1.2%) 137.24M -7.3M (-5.1%) 0.36% -0.004 pp 0.04% -0.009 pp USD139.73 -2.6% 19 qtrs
43 ALLIANCEBERNSTEIN L.P. 969.6K +154.3K (+18.9%) 131.94M +27.3M (+26.1%) 0.34% +0.055 pp 0.04% +0.009 pp USD109.43 +24.3% 61 qtrs
44 JANE STREET GROUP, LLC 924.7K +868.6K (+1,548.8%) 125.82M +118.6M (+1,648.0%) 0.33% +0.307 pp 0.02% +0.018 pp USD135.95 +0.1% 48 qtrs
45 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 919.4K +494.0K (+116.1%) 125.10M +70.5M (+129.1%) 0.32% +0.175 pp 0.07% +0.039 pp USD131.29 +3.6% 21 qtrs
46 CANDRIAM S.C.A. 913.1K +30.9K (+3.5%) 124.25M +11.0M (+9.7%) 0.32% +0.011 pp 0.62% +0.026 pp USD126.49 +7.6% 45 qtrs
47 BESSEMER GROUP INC 908.3K +23.1K (+2.6%) 123.59M +10.0M (+8.8%) 0.32% +0.008 pp 0.19% +0.016 pp USD103.13 +31.9% 39 qtrs
48 UBS GROUP AG 895.3K +90.2K (+11.2%) 121.82M +18.5M (+17.9%) 0.32% +0.032 pp 0.02% +0.004 pp USD129.09 +5.4% 45 qtrs
49 ROYAL BANK OF CANADA 886.7K +111.2K (+14.3%) 120.65M +21.1M (+21.2%) 0.31% +0.039 pp 0.02% +0.003 pp USD129.38 +5.2% 51 qtrs
50 ILEX CAPITAL PARTNERS (UK) LLP 882.5K +249.8K (+39.5%) 120.09M +38.9M (+47.9%) 0.31% +0.088 pp 3.39% +0.796 pp USD123.12 +10.5% 6 qtrs
51 BNP PARIBAS ARBITRAGE, SNC 844.1K +337.2K (+66.5%) 114.85M +49.8M (+76.5%) 0.30% +0.119 pp 0.05% +0.017 pp USD130.42 +4.3% 51 qtrs
52 MILLENNIUM MANAGEMENT LLC 838.5K -682.3K (-44.9%) 114.09M -81.1M (-41.6%) 0.30% -0.241 pp 0.05% -0.035 pp USD131.67 +3.3% 75 qtrs
53 M&G PLC 820.9K -90.8K (-10.0%) 111.64M -5.1M (-4.3%) 0.29% -0.032 pp 0.57% -0.047 pp USD125.82 +8.1% 8 qtrs
54 CHAMPLAIN INVESTMENT PARTNERS, LLC 808.3K -87.5K (-9.8%) 109.98M -5.0M (-4.3%) 0.29% -0.031 pp 1.11% +0.247 pp USD134.47 +1.2% 8 qtrs
55 SG AMERICAS SECURITIES, LLC 808.2K +782.9K (+3,091.1%) 109.97M +106.7M (+3,282.8%) 0.29% +0.277 pp 0.14% +0.130 pp USD135.91 +0.1% 51 qtrs
56 FINDLAY PARK PARTNERS LLP 804.8K -745.8K (-48.1%) 109.50M -89.5M (-45.0%) 0.28% -0.264 pp 1.40% -0.693 pp USD119.64 +13.7% 10 qtrs
57 MAN GROUP PLC 787.4K +276.7K (+54.2%) 107.14M +41.6M (+63.5%) 0.28% +0.098 pp 0.18% +0.068 pp USD131.49 +3.5% 32 qtrs
58 LGT CAPITAL PARTNERS LTD. 786.6K -9.5K (-1.2%) 107.03M +4.9M (+4.8%) 0.28% -0.003 pp 5.31% +0.351 pp USD112.33 +21.1% 27 qtrs
59 NUVEEN, LLC 786.6K -73.9K (-8.6%) 107.03M -3.4M (-3.1%) 0.28% -0.026 pp 0.03% -0.001 pp USD117.76 +15.5% 4 qtrs
60 BARCLAYS PLC 780.8K +27.0K (+3.6%) 106.24M -5.7M (-5.1%) 0.28% +0.011 pp 0.03% -0.003 pp USD128.31 +6.0% 51 qtrs
61 SWISS NATIONAL BANK 776.7K -42.1K (-5.1%) 105.69M +592.6K (+0.6%) 0.27% -0.015 pp 0.06% +0.002 pp USD68.16 +99.6% 51 qtrs
62 LAZARD ASSET MANAGEMENT LLC 772.4K +71.6K (+10.2%) 105.09M +15.2M (+16.9%) 0.27% +0.025 pp 0.18% +0.057 pp USD119.86 +13.5% 41 qtrs
63 HSBC HOLDINGS PLC 753.7K +16.6K (+2.3%) 102.64M +8.1M (+8.6%) 0.27% +0.006 pp 0.05% +0.000 pp USD118.82 +14.5% 56 qtrs
64 LIONTRUST INVESTMENT PARTNERS LLP 705.8K -63.0K (-8.2%) 96.04M -2.6M (-2.7%) 0.25% -0.022 pp 1.43% +0.038 pp USD120.23 +13.2% 14 qtrs
65 FIRST TRUST ADVISORS LP 696.0K +29.3K (+4.4%) 94.70M +9.1M (+10.7%) 0.25% +0.010 pp 0.07% +0.005 pp USD128.30 +6.1% 51 qtrs
66 ALLIANZ ASSET MANAGEMENT GMBH 676.0K -77.4K (-10.3%) 91.99M -4.7M (-4.9%) 0.24% -0.027 pp 0.09% -0.015 pp USD115.00 +18.3% 51 qtrs
67 ENVESTNET ASSET MANAGEMENT INC 655.2K +47.3K (+7.8%) 89.16M +11.1M (+14.3%) 0.23% +0.017 pp 0.03% +0.004 pp USD125.17 +8.7% 51 qtrs
68 SUMITOMO MITSUI TRUST HOLDINGS, INC. 636.7K -32.8K (-4.9%) 86.64M +704.1K (+0.8%) 0.23% -0.012 pp 0.05% +0.001 pp USD84.67 +60.7% 59 qtrs
69 SUMMITRY LLC 623.5K +45.0 (+0.0%) 84.84M +4.8M (+6.0%) 0.22% +0.000 pp 3.54% +0.154 pp USD105.41 +29.1% 24 qtrs
70 MADISON ASSET MANAGEMENT, LLC 609.4K -44.4K (-6.8%) 82.92M -994.2K (-1.2%) 0.22% -0.016 pp 0.95% +0.028 pp USD125.40 +8.5% 10 qtrs
71 MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 599.6K +24.7K (+4.3%) 82.71M +8.9M (+12.1%) 0.21% +0.009 pp 0.06% +0.003 pp USD122.40 +11.2% 58 qtrs
72 JENNISON ASSOCIATES LLC 606.3K +279.8K (+85.7%) 82.50M +40.6M (+96.8%) 0.21% +0.099 pp 0.05% +0.025 pp USD138.68 -1.9% 8 qtrs
73 RUSSELL INVESTMENTS GROUP, LTD. 597.1K +10.5K (+1.8%) 81.31M +6.1M (+8.1%) 0.21% +0.004 pp 0.09% +0.003 pp USD123.44 +10.2% 37 qtrs
74 FENIMORE ASSET MANAGEMENT INC 595.0K +8.5K (+1.4%) 80.96M +5.7M (+7.5%) 0.21% +0.003 pp 1.69% +0.177 pp USD131.59 +3.4% 9 qtrs
75 CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 583.9K -5.7K (-1.0%) 79.46M +3.8M (+5.0%) 0.21% -0.002 pp 0.05% +0.000 pp USD81.95 +66.0% 53 qtrs
76 PARNASSUS INVESTMENTS, LLC 580.9K +120.5K (+26.2%) 79.05M +19.9M (+33.8%) 0.21% +0.043 pp 0.21% +0.068 pp USD102.75 +32.4% 26 qtrs
77 UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 577.1K -54.3K (-8.6%) 78.67M -2.4M (-2.9%) 0.20% -0.019 pp 0.13% -0.007 pp USD126.80 +7.3% 5 qtrs
78 CITADEL ADVISORS LLC 558.7K +166.0K (+42.3%) 76.02M +25.6M (+50.8%) 0.20% +0.059 pp 0.01% +0.004 pp USD127.56 +6.7% 52 qtrs
79 SCHARF INVESTMENTS, LLC 531.2K -36.6K (-6.4%) 72.29M -595.7K (-0.8%) 0.19% -0.013 pp 1.94% +0.110 pp USD128.35 +6.0% 2 qtrs
80 RHUMBLINE ADVISERS 514.5K -12.8K (-2.4%) 70.01M +2.3M (+3.4%) 0.18% -0.005 pp 0.06% +0.002 pp USD65.70 +107.1% 51 qtrs
81 MARSHALL WACE, LLP 506.2K -1.1M (-68.2%) 68.88M -135.4M (-66.3%) 0.18% -0.384 pp 0.06% -0.145 pp USD125.74 +8.2% 16 qtrs
82 JUPITER ASSET MANAGEMENT LTD 499.1K +340.0 (+0.1%) 67.91M +3.9M (+6.1%) 0.18% +0.000 pp 0.54% -0.006 pp USD132.64 +2.6% 31 qtrs
83 BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 480.8K +20.8K (+4.5%) 65.44M +6.4M (+10.8%) 0.17% +0.007 pp 0.08% -0.078 pp USD120.48 +12.9% 51 qtrs
84 EARNEST PARTNERS LLC 474.6K -1.4K (-0.3%) 64.57M +3.5M (+5.7%) 0.17% -0.001 pp 0.28% +0.012 pp USD91.65 +48.5% 51 qtrs
85 STEADFAST CAPITAL MANAGEMENT LP 452.3K +60.3K (+15.4%) 61.55M +11.2M (+22.3%) 0.16% +0.021 pp 1.06% +0.178 pp USD129.38 +5.2% 2 qtrs
86 RAYMOND JAMES FINANCIAL INC 451.6K +16.1K (+3.7%) 61.45M +5.6M (+9.9%) 0.16% +0.006 pp 0.02% +0.001 pp USD132.81 +2.5% 5 qtrs
87 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 447.5K -21.0K (-4.5%) 60.89M +756.8K (+1.3%) 0.16% -0.007 pp 0.06% -0.001 pp USD44.87 +203.3% 55 qtrs
88 NATIONAL PENSION SERVICE 438.2K -569.0 (-0.1%) 59.63M +3.3M (+5.9%) 0.15% 0.000 pp 0.04% +0.000 pp USD88.91 +53.0% 46 qtrs
89 PRICE T ROWE ASSOCIATES INC /MD/ 433.5K -11.9K (-2.7%) 58.99M +1.8M (+3.2%) 0.15% -0.004 pp 0.01% +0.000 pp USD78.87 +72.5% 75 qtrs
90 WELLS FARGO & COMPANY/MN 422.6K -19.7K (-4.5%) 57.51M +732.5K (+1.3%) 0.15% -0.007 pp 0.01% 0.000 pp USD97.03 +40.2% 57 qtrs
91 NORTHWEST & ETHICAL INVESTMENTS L.P. 417.5K -30.3K (-6.8%) 56.81M -660.0K (-1.1%) 0.15% -0.011 pp 1.28% -0.078 pp USD107.86 +26.2% 40 qtrs
92 HARVEST PORTFOLIOS GROUP INC. 407.8K -84.8K (-17.2%) 55.49M -7.7M (-12.2%) 0.14% -0.030 pp 0.96% -0.201 pp USD133.86 +1.7% 9 qtrs
93 WALLEYE CAPITAL LLC 403.9K +252.5K (+166.7%) 54.96M +35.5M (+182.8%) 0.14% +0.089 pp 0.17% +0.096 pp USD133.17 +2.2% 11 qtrs
94 SCHONFELD STRATEGIC ADVISORS LLC 396.1K +386.3K (+3,940.2%) 53.90M +52.6M (+4,183.2%) 0.14% +0.137 pp 0.24% +0.232 pp USD135.96 +0.1% 10 qtrs
95 QUANTINNO CAPITAL MANAGEMENT LP 382.2K +131.8K (+52.6%) 52.01M +19.9M (+61.8%) 0.14% +0.047 pp 0.10% +0.017 pp USD130.93 +3.9% 17 qtrs
96 PANAGORA ASSET MANAGEMENT INC 380.5K +110.7K (+41.0%) 51.77M +17.1M (+49.5%) 0.13% +0.039 pp 0.18% +0.044 pp USD134.89 +0.9% 67 qtrs
97 WORLDQUANT MILLENNIUM ADVISORS LLC 366.5K +173.1K (+89.5%) 49.87M +25.1M (+100.9%) 0.13% +0.061 pp 0.19% +0.086 pp USD140.85 -3.4% 13 qtrs
98 SUSQUEHANNA INTERNATIONAL GROUP, LLP 365.4K -300.0 (-0.1%) 49.72M +2.8M (+5.9%) 0.13% 0.000 pp 0.01% +0.000 pp USD122.14 +11.4% 51 qtrs
99 DANSKE BANK A/S 356.8K -44.6K (-11.1%) 48.56M -3.0M (-5.8%) 0.13% -0.016 pp 0.11% -0.015 pp USD131.10 +3.8% 8 qtrs
100 PRINCIPAL FINANCIAL GROUP INC 339.9K +6.1K (+1.8%) 46.24M +3.4M (+8.0%) 0.12% +0.002 pp 0.02% +0.002 pp USD118.51 +14.8% 81 qtrs
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
3.00
Bullish
Buys
1
Sells
1
Shares acquired
8.9K
Shares disposed
368.00
Cash buys
Cash sales
Net activity
+8,504
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-05-19 Buckner Michael Steven Officer A-Award A Common Stock 8,872 0.00 8,887 D
2026-05-08 MAY SIMON Officer F-InKind D Common Stock 368 115.62 42.5K 14,015 D
2026-05-04 Buckner Michael Steven Officer Common Stock 0 0.00 15 D
2026-03-31 Henson Meghan Officer F-InKind D Common Stock 153 113.98 17.4K 6,890 D
2026-03-19 WILSON DOW R Director A-Award A Common Stock 2,158 111.75 241.2K 20,369 D
2026-03-19 Soriot Pascal Director F-InKind D Common Stock 648 111.75 72.4K 2,683 D
2026-03-19 SCANGOS GEORGE A Director A-Award A Common Stock 2,158 111.75 241.2K 22,800 D
2026-03-19 Rataj Sue H. Director A-Award A Common Stock 2,158 111.75 241.2K 23,617 D
2026-03-19 Podolsky Daniel K Director A-Award A Common Stock 2,158 111.75 241.2K 38,180 D
2026-03-19 KOH BOON HWEE Director F-InKind D Common Stock 648 111.75 72.4K 63,184 D
2026-03-19 Dolsten Mikael Director A-Award A Common Stock 2,158 111.75 241.2K 7,138 D
2026-03-19 Brown Judy L Director A-Award A Common Stock 2,158 111.75 241.2K 3,835 D
2026-03-19 BRAWLEY OTIS W Director A-Award A Common Stock 2,158 111.75 241.2K 12,986 D
2026-03-19 Anand Mala Director A-Award A Common Stock 2,158 111.75 241.2K 16,705 D
2026-02-27 RIEMANN ANGELICA Officer F-InKind D Common Stock 89 121.38 10.8K 26,535 D
2026-02-27 MCDONNELL PADRAIG Director / Officer F-InKind D Common Stock 279 121.38 33.9K 66,260 D
2026-02-27 KIRKWOOD JONAH PREVOST Officer F-InKind D Common Stock 124 121.38 15.1K 14,138 D
2025-12-01 Dolsten Mikael Director S-Sale D Common Stock 2,600 149.81 389.5K 4,973 D
2025-11-26 ZHANG JIANMIAO MIKE Officer F-InKind D Common Stock 208 154.37 32.1K 11,639 D
2025-11-26 RIEMANN ANGELICA Officer F-InKind D Common Stock 280 154.37 43.2K 26,594 D
2025-11-26 MCDONNELL PADRAIG Director / Officer F-InKind D Common Stock 1,948 154.37 300.7K 66,539 D
2025-11-26 MAY SIMON Officer F-InKind D Common Stock 300 154.37 46.3K 14,207 D
2025-11-26 KIRKWOOD JONAH PREVOST Officer F-InKind D Common Stock 430 154.37 66.4K 14,262 D
2025-11-26 Gonsalves Rodney Officer S-Sale D Common Stock 3,000 154.99 465.0K 31,846 D
2025-11-26 DiMarco Bret Officer F-InKind D Common Stock 332 154.37 51.3K 12,203 D
2025-11-21 ZHANG JIANMIAO MIKE Officer F-InKind D Common Stock 67 151.25 10.1K 11,847 D
2025-11-21 RIEMANN ANGELICA Officer F-InKind D Common Stock 75 151.25 11.3K 26,874 D
2025-11-21 MCDONNELL PADRAIG Director / Officer F-InKind D Common Stock 541 151.25 81.8K 68,487 D
2025-11-21 KIRKWOOD JONAH PREVOST Officer F-InKind D Common Stock 113 151.25 17.1K 14,692 D
2025-11-21 Gonsalves Rodney Officer F-InKind D Common Stock 138 151.25 20.9K 34,846 D
2025-11-18 ZHANG JIANMIAO MIKE Officer F-InKind D Common Stock 452 143.84 65.0K 6,687 D
2025-11-18 RIEMANN ANGELICA Officer F-InKind D Common Stock 489 143.84 70.3K 20,168 D
2025-11-18 MCDONNELL PADRAIG Director / Officer S-Sale D Common Stock 911 143.24 130.5K 32,058 D
2025-11-18 MAY SIMON Officer A-Award A Common Stock 6,781 0.00 14,507 D
2025-11-18 KIRKWOOD JONAH PREVOST Officer A-Award A Common Stock 1,438 0.00 9,502 D
2025-11-18 Henson Meghan Officer A-Award A Common Stock 5,368 0.00 7,043 D
2025-11-18 Gonsalves Rodney Officer F-InKind D Common Stock 883 143.84 127.0K 32,582 D
2025-11-18 Elinoff Adam Stewart Officer Common Stock 0 0.00 0 D
2025-11-18 DiMarco Bret Officer A-Award A Common Stock 6,922 0.00 12,535 D
2025-11-14 ZHANG JIANMIAO MIKE Officer F-InKind D Common Stock 51 146.82 7.5K 5,718 D
2025-11-14 RIEMANN ANGELICA Officer F-InKind D Common Stock 56 146.82 8.2K 19,164 D
2025-11-14 MCDONNELL PADRAIG Director / Officer F-InKind D Common Stock 203 146.82 29.8K 33,245 D
2025-11-14 KIRKWOOD JONAH PREVOST Officer F-InKind D Common Stock 58 146.82 8.5K 8,064 D
2025-11-14 Gonsalves Rodney Officer F-InKind D Common Stock 77 146.82 11.3K 31,024 D
2025-11-12 MCDONNELL PADRAIG Director / Officer M-Exempt A Common Stock 12,490 109.86 1.37M 45,938 D
2025-09-02 MCDONNELL PADRAIG Director / Officer S-Sale D Common Stock 2,000 124.88 249.8K 33,448 D
2025-08-01 MCDONNELL PADRAIG Director / Officer S-Sale D Common Stock 2,000 113.45 226.9K 35,448 D
2025-07-16 Gonsalves Rodney Officer A-Award A Common Stock 9,031 113.43 1.02M 30,972 D
2025-07-02 DiMarco Bret Officer F-InKind D Common Stock 141 120.66 17.0K 5,475 D
2025-07-01 MCDONNELL PADRAIG Director / Officer S-Sale D Common Stock 1,508 117.44 177.1K 37,448 D
2025-06-27 KIRKWOOD JONAH PREVOST Officer F-InKind D Common Stock 30 119.17 3.6K 8,159 D
2025-06-18 Brown Judy L Director S-Sale D Common Stock 8 116.53 904.30 1,677 D
2025-06-03 MCDONNELL PADRAIG Director / Officer F-InKind D Common Stock 418 112.76 47.1K 38,956 D
2025-05-30 Ancher-Jensen Henrik Officer F-InKind D Common Stock 1,755 111.92 196.4K 86,426 D
2025-05-22 McMahon Robert W. Officer F-InKind D Common Stock 3,499 109.68 383.8K 168,754 D
2025-05-21 Soriot Pascal Director F-InKind D Common Stock 504 108.91 54.9K 1,173 D
2025-05-21 Brown Judy L Director A-Award A Common Stock 1,677 108.91 182.6K 1,685 D
2025-05-20 Soriot Pascal Director Common Stock 0 0.00 0 D
2025-05-20 Brown Judy L Director Common Stock 0 0.00 8 D
2025-05-08 MAY SIMON Officer F-InKind D Common Stock 368 108.70 40.0K 7,491 D
2025-05-02 Ancher-Jensen Henrik Officer F-InKind D Common Stock 132 108.63 14.3K 88,181 D
2025-03-31 Podolsky Daniel K Director S-Sale D Common Stock 1,819 116.46 211.8K 35,737 D
2025-03-17 Gonsalves Rodney Officer S-Sale D Common Stock 1,908 121.98 232.7K 21,786 D
2025-03-14 WILSON DOW R Director A-Award A Common Stock 1,819 121.18 220.4K 18,066 D
2025-03-14 SCANGOS GEORGE A Director A-Award A Common Stock 1,819 121.18 220.4K 20,493 D
2025-03-14 Rataj Sue H. Director A-Award A Common Stock 1,819 121.18 220.4K 21,459 D
2025-03-14 Podolsky Daniel K Director A-Award A Common Stock 1,819 121.18 220.4K 37,556 D
2025-03-14 KOH BOON HWEE Director F-InKind D Common Stock 546 121.18 66.2K 61,568 D
2025-03-14 FIELDS HEIDI Director A-Award A Common Stock 1,819 121.18 220.4K 58,851 I
2025-03-14 Dolsten Mikael Director A-Award A Common Stock 1,819 121.18 220.4K 7,550 D
2025-03-14 BRAWLEY OTIS W Director A-Award A Common Stock 1,819 121.18 220.4K 9,930 D
2025-03-14 Anand Mala Director A-Award A Common Stock 1,819 121.18 220.4K 14,547 D
2025-03-06 Rataj Sue H. Director S-Sale D Common Stock 6,971 126.38 881.0K 19,640 D
2025-03-05 McMahon Robert W. Officer A-Award A Common Stock 5,385 126.51 681.3K 172,191 D
2025-03-01 KIRKWOOD JONAH PREVOST Officer Employee Stock Option (Right to Buy) 2,609 139.06 362.8K 0 D
2025-02-28 RIEMANN ANGELICA Officer F-InKind D Common Stock 84 127.92 10.7K 18,993 D
2025-02-28 MCDONNELL PADRAIG Director / Officer F-InKind D Common Stock 278 127.92 35.6K 39,374 D
2025-02-28 KIRKWOOD JONAH PREVOST Officer F-InKind D Common Stock 124 127.92 15.9K 8,189 D
2025-01-28 Gonsalves Rodney Officer G-Gift D Common Stock 7,149 150.34 1.07M 40 I
2025-01-21 MCDONNELL PADRAIG Director / Officer S-Sale D Common Stock 1,911 150.00 286.7K 39,652 D
2024-11-29 Ancher-Jensen Henrik Officer F-InKind D Common Stock 2,577 137.97 355.5K 88,097 D
2024-11-27 ZHANG JIANMIAO MIKE Officer A-Award A Common Stock 2,569 138.14 354.9K 5,796 D
2024-11-27 RIEMANN ANGELICA Officer A-Award A Employee Stock Option (Right to Buy) 9,272 138.14 1.28M 9,272 D
2024-11-27 McMahon Robert W. Officer A-Award A Employee Stock Option (Right to Buy) 18,544 138.14 2.56M 18,544 D
2024-11-27 MCDONNELL PADRAIG Director / Officer A-Award A Employee Stock Option (Right to Buy) 45,202 138.14 6.24M 45,202 D
2024-11-27 MAY SIMON Officer A-Award A Common Stock 3,452 138.14 476.9K 7,687 D
2024-11-27 KIRKWOOD JONAH PREVOST Officer A-Award A Common Stock 3,212 138.14 443.7K 8,313 D
2024-11-27 Gonsalves Rodney Officer A-Award A Common Stock 1,365 138.14 188.6K 23,671 D
2024-11-27 DiMarco Bret Officer A-Award A Common Stock 3,814 138.14 526.9K 5,432 D
2024-11-27 Ancher-Jensen Henrik Officer A-Award A Employee Stock Option (Right to Buy) 12,517 138.14 1.73M 12,517 D
2024-11-22 ZHANG JIANMIAO MIKE Officer Employee Stock Option (Right to Buy) 2,382 123.99 295.3K 0 D
2024-11-22 RIEMANN ANGELICA Officer D Employee Stock Option (Right to Buy) 2,522 123.99 312.7K 0
2024-11-22 McMahon Robert W. Officer F-InKind D Common Stock 5,775 133.84 772.9K 160,340 D
2024-11-22 MCDONNELL PADRAIG Director / Officer F-InKind D Common Stock 448 133.84 60.0K 25,907 D
2024-11-22 KIRKWOOD JONAH PREVOST Officer Employee Stock Option (Right to Buy) 2,382 123.99 295.3K 0 D
2024-11-22 Gonsalves Rodney Officer F-InKind D Common Stock 138 133.84 18.5K 22,306 D
2024-11-22 Ancher-Jensen Henrik Officer F-InKind D Common Stock 581 133.84 77.8K 86,338 D
2024-11-20 ZHANG JIANMIAO MIKE Officer Common Stock 0 0.00 3,292 D
2024-11-20 KIRKWOOD JONAH PREVOST Officer Common Stock 0 0.00 5,214 D
2024-11-19 RIEMANN ANGELICA Officer F-InKind D Common Stock 327 125.69 41.1K 15,896 D
2024-11-19 McMahon Robert W. Officer F-InKind D Common Stock 2,196 125.69 276.0K 166,115 D
2024-11-19 MCDONNELL PADRAIG Director / Officer A-Award A Common Stock 4,505 125.69 566.2K 27,861 D
2024-11-19 Gonsalves Rodney Officer F-InKind D Common Stock 591 125.69 74.3K 22,444 D
2024-11-19 Binns Philip Officer A-Award A Common Stock 653 125.69 82.1K 10,650 D
2024-11-19 Ancher-Jensen Henrik Officer F-InKind D Common Stock 2,991 125.69 375.9K 86,919 D
2024-11-15 RIEMANN ANGELICA Officer F-InKind D Common Stock 172 127.07 21.9K 15,178 D
2024-11-15 McMahon Robert W. Officer F-InKind D Common Stock 1,295 127.07 164.6K 160,476 D
2024-11-15 MCDONNELL PADRAIG Director / Officer F-InKind D Common Stock 715 127.07 90.9K 23,356 D
2024-11-15 Gonsalves Rodney Officer F-InKind D Common Stock 276 127.07 35.1K 21,337 D
2024-11-15 Ancher-Jensen Henrik Officer F-InKind D Common Stock 796 127.07 101.1K 81,956 D
2024-09-27 MCDONNELL PADRAIG Director / Officer S-Sale D Common Stock 47 150.00 7.1K 24,071 D
2024-09-26 Grau Dominique Officer S-Sale D Common Stock 5,010 145.00 726.5K 46,762 I
2024-08-22 MCDONNELL PADRAIG Director / Officer S-Sale D Common Stock 1,958 145.00 283.9K 24,118
2024-07-26 MCDONNELL PADRAIG Director / Officer S-Sale D Common Stock 1,958 140.00 274.1K 26,076
2024-07-02 DiMarco Bret Officer A-Award A Employee Stock Option (Right to Buy) 4,595 125.78 578.0K 4,595
2024-07-01 DiMarco Bret Officer D Common Stock 0 0.00 0
2024-06-27 KIRKWOOD JONAH PREVOST Officer Employee Stock Option (Right to Buy) 646 117.04 75.6K 0 D
2024-06-18 MCDONNELL PADRAIG Director / Officer S-Sale D Common Stock 1,958 135.00 264.3K 28,034
2024-06-10 Grau Dominique Officer S-Sale D Common Stock 15,000 133.28 2.00M 49,486
2024-06-05 Grau Dominique Officer G-Gift A Common Stock 515 133.56 68.8K 52,802
2024-06-03 MCDONNELL PADRAIG Director / Officer A-Award A Common Stock 4,807 131.40 631.6K 29,992
2024-05-29 SCANGOS GEORGE A Director G-Gift A Common Stock 3,443 145.48 500.9K 17,893
2024-05-17 RIEMANN ANGELICA Officer F-InKind D Common Stock 26 154.23 4.0K 15,255
2024-05-17 MCDONNELL PADRAIG Director / Officer F-InKind D Common Stock 174 154.23 26.8K 27,143
2024-05-08 MAY SIMON Officer A-Award A Employee Stock Option (Right to Buy) 11,792 142.80 1.68M 11,792
2024-05-06 MAY SIMON Officer 0 0.00 0
2024-05-03 Ancher-Jensen Henrik Officer F-InKind D Common Stock 132 139.45 18.4K 82,560
2024-03-25 Binns Philip Officer S-Sale D Common Stock 2,827 147.54 417.1K 9,997
2024-03-15 WILSON DOW R Director A-Award A Common Stock 1,678 147.48 247.5K 16,136
2024-03-15 SCANGOS GEORGE A Director A-Award A Common Stock 1,678 147.48 247.5K 21,989
2024-03-15 Rataj Sue H. Director A-Award A Common Stock 1,678 147.48 247.5K 26,611
2024-03-15 Podolsky Daniel K Director A-Award A Common Stock 1,678 147.48 247.5K 35,082
2024-03-15 KOH BOON HWEE Director F-InKind D Common Stock 504 147.48 74.3K 60,204
2024-03-15 FIELDS HEIDI Director A-Award A Common Stock 1,678 147.48 247.5K 56,654
2024-03-15 Dolsten Mikael Director A-Award A Common Stock 1,678 147.48 247.5K 5,711
2024-03-15 Bishop Hans Edgar Director A-Award A Common Stock 750 147.48 110.6K 24,976
2024-03-15 BRAWLEY OTIS W Director A-Award A Common Stock 1,678 147.48 247.5K 7,305
2024-03-15 Anand Mala Director A-Award A Common Stock 1,678 147.48 247.5K 12,728
2024-03-08 McMullen Michael R. Director / Officer S-Sale D Common Stock 52,297 150.00 7.84M 253,909
2024-03-07 Gonsalves Rodney Officer S-Sale D Common Stock 4,828 149.00 719.3K 21,329
2024-03-05 FIELDS HEIDI Director S-Sale D Common Stock 1,658 144.34 239.3K 54,976
2024-03-01 RIEMANN ANGELICA Officer A-Award A Common Stock 880 139.06 122.4K 15,085
2024-03-01 MCDONNELL PADRAIG Officer A-Award A Common Stock 3,202 139.06 445.3K 27,317
2024-02-20 RIEMANN ANGELICA Officer D Common Stock 0 0.00 14,205
2023-12-27 Binns Philip Officer S-Sale D Common Stock 2,880 139.78 402.6K 12,824
2023-12-18 Gonsalves Rodney Officer S-Sale D Common Stock 1,500 137.69 206.5K 26,133
2023-12-15 Ancher-Jensen Henrik Officer M-Exempt D Employee Stock Option (Right-to-Buy) 10,304 109.86 1.13M 3,435
2023-12-13 McMullen Michael R. Director / Officer M-Exempt A Common Stock 2,751 42.12 115.9K 308,957
2023-12-07 McMullen Michael R. Director / Officer S-Sale D Common Stock 62,467 130.00 8.12M 306,206
2023-12-01 Grau Dominique Officer A-Award A Common Stock 16,614 128.79 2.14M 64,861
2023-12-01 Ancher-Jensen Henrik Officer A-Award A Common Stock 16,614 128.79 2.14M 97,132
2023-11-22 Tang Michael Officer A-Award A Common Stock 4,150 123.99 514.6K 54,872
2023-11-22 McMullen Michael R. Director / Officer A-Award A Employee Stock Option (Right to Buy) 71,449 123.99 8.86M 71,449
2023-11-22 McMahon Robert W. Officer A-Award A Employee Stock Option (Right to Buy) 20,734 123.99 2.57M 20,734
2023-11-22 MCDONNELL PADRAIG Officer A-Award A Employee Stock Option (Right to Buy) 12,328 123.99 1.53M 12,328
2023-11-22 Grau Dominique Officer A-Award A Employee Stock Option (Right to Buy) 11,488 123.99 1.42M 11,488
2023-11-22 Gonsalves Rodney Officer A-Award A Common Stock 1,581 123.99 196.0K 27,633
2023-11-22 Binns Philip Officer A-Award A Employee Stock Option (Right to Buy) 10,087 123.99 1.25M 10,087
2023-11-22 Ancher-Jensen Henrik Officer A-Award A Employee Stock Option (Right to Buy) 14,010 123.99 1.74M 14,010
2023-11-17 Tang Michael Officer F-InKind D Common Stock 1,446 113.15 163.6K 50,722
2023-11-17 Raha Samraat S. Officer F-InKind D Common Stock 1,578 113.15 178.6K 85,108
2023-11-17 McMullen Michael R. Director / Officer F-InKind D Common Stock 10,206 113.15 1.15M 281,011
2023-11-17 McMahon Robert W. Officer F-InKind D Common Stock 2,429 113.15 274.8K 125,038
2023-11-17 MCDONNELL PADRAIG Officer F-InKind D Common Stock 587 113.15 66.4K 19,768
2023-11-17 Grau Dominique Officer F-InKind D Common Stock 1,587 113.15 179.6K 44,196
2023-11-17 Gonsalves Rodney Officer F-InKind D Common Stock 356 113.15 40.3K 26,052
2023-11-17 Ancher-Jensen Henrik Officer F-InKind D Common Stock 1,382 113.15 156.4K 75,578
2023-11-16 Tang Michael Officer F-InKind D Common Stock 286 114.19 32.7K 52,168
2023-11-16 Raha Samraat S. Officer F-InKind D Common Stock 345 114.19 39.4K 86,686
2023-11-16 McMullen Michael R. Director / Officer F-InKind D Common Stock 2,013 114.19 229.9K 291,217
2023-11-16 McMahon Robert W. Officer F-InKind D Common Stock 504 114.19 57.6K 127,467
2023-11-16 MCDONNELL PADRAIG Officer F-InKind D Common Stock 290 114.19 33.1K 20,355
2023-11-16 Grau Dominique Officer F-InKind D Common Stock 349 114.19 39.9K 45,783
2023-11-16 Gonsalves Rodney Officer F-InKind D Common Stock 77 114.19 8.8K 26,408
2023-11-16 Ancher-Jensen Henrik Officer F-InKind D Common Stock 375 114.19 42.8K 76,960
2023-11-15 ZHANG JIANMIAO MIKE Officer Employee Stock Option (Right to Buy) 1,856 148.00 274.7K 0 D
2023-11-15 Tang Michael Officer F-InKind D Common Stock 359 113.60 40.8K 52,454
2023-11-15 Raha Samraat S. Officer F-InKind D Common Stock 428 113.60 48.6K 87,031
2023-11-15 RIEMANN ANGELICA Officer D Employee Stock Option (Right to Buy) 1,949 148.00 288.5K 0
2023-11-15 McMullen Michael R. Director / Officer F-InKind D Common Stock 2,510 113.60 285.1K 293,230
2023-11-15 McMahon Robert W. Officer F-InKind D Common Stock 664 113.60 75.4K 127,971
2023-11-15 MCDONNELL PADRAIG Officer F-InKind D Common Stock 394 113.60 44.8K 20,645
2023-11-15 KIRKWOOD JONAH PREVOST Officer Employee Stock Option (Right to Buy) 1,253 148.00 185.4K 0 D
2023-11-15 Grau Dominique Officer F-InKind D Common Stock 369 113.60 41.9K 46,132
2023-11-15 Gonsalves Rodney Officer F-InKind D Common Stock 98 113.60 11.1K 26,485
2023-11-15 Binns Philip Officer D Employee Stock Option (Right to Buy) 1,160 148.00 171.7K 0
2023-11-15 Ancher-Jensen Henrik Officer F-InKind D Common Stock 406 113.60 46.1K 77,335
2023-11-14 Tang Michael Officer F-InKind D Common Stock 3,471 111.61 387.4K 52,813
2023-11-14 Raha Samraat S. Officer A-Award A Common Stock 11,225 111.61 1.25M 90,630
2023-11-14 McMullen Michael R. Director / Officer F-InKind D Common Stock 31,877 111.61 3.56M 295,740
2023-11-14 McMahon Robert W. Officer F-InKind D Common Stock 4,248 111.61 474.1K 128,635
2023-11-14 MCDONNELL PADRAIG Officer A-Award A Common Stock 9,101 111.61 1.02M 24,459
2023-11-14 Grau Dominique Officer A-Award A Common Stock 9,709 111.61 1.08M 49,979
2023-11-14 Gonsalves Rodney Officer A-Award A Common Stock 3,490 111.61 389.5K 27,791
2023-11-14 Binns Philip Officer A-Award A Common Stock 1,396 111.61 155.8K 12,147
2023-11-14 Ancher-Jensen Henrik Officer A-Award A Common Stock 10,012 111.61 1.12M 81,178
2023-09-28 Gonsalves Rodney Officer P-Purchase D Common Stock 0 0.00 24,219
2023-09-11 Binns Philip Officer A-Award A Employee Stock Option (Right to Buy) 6,261 113.10 708.1K 6,261
2023-09-05 Binns Philip Officer D Common Stock 0 0.00 8,548
2023-08-23 Gonsalves Rodney Officer S-Sale D Common Stock 3,500 118.78 415.7K 24,219

Executive team

Top executives
EBIT / Employee
86.4K
Shares Outstanding
282.60M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Padraig McDonnell President; Chief Executive Officer 1.14M 8.17M 2.02M 1.44M 61.5K 12.83M 79.42%
2 2025 Robert McMahon Former Senior Vice President; Former Chief Financial Officer 665.0K 4.00M 827.8K 44.6K 5.54M 87.19%
3 2025 Simon May Senior Vice President, Agilent President Life Sciences and Diagnostics Market Group 635.4K 500.0K 1.80M 445.0K 472.4K 17.4K 3.87M 58.02%
4 2025 Bret DiMarco Senior Vice President, Chief Legal Officer 679.8K 1.99M 491.5K 475.5K 21.6K 3.66M 67.83%
5 2025 Angelica Riemann Senior Vice President, Agilent President Agilent Cross-Lab Group 591.3K 1.68M 413.9K 520.5K 13.0K 3.21M 65.01%
6 2025 Rodney Gonsalves Vice President; Controller; Interim Chief Financial Officer 513.6K 1.69M 175.9K 291.6K 26.9K 2.70M 69.13%
7 2024 Michael R. McMullen Former Chief Executive Officer 1.21M 11.70M 2.92M 713.6K 90.5K 16.62M 87.89%
8 2024 Padraig McDonnell Chief Executive Officer 870.0K 5.98M 1.50M 669.3K 21.3K 9.05M 82.75%
9 2024 Padraig McDonnell President; Chief Executive Officer 870.0K 5.98M 1.50M 669.3K 21.3K 9.05M 82.75%
10 2024 Robert McMahon Former Senior Vice President; Former Chief Financial Officer 756.7K 6.87M 845.9K 324.6K 84.0K 8.88M 86.88%
11 2024 Robert McMahon Senior Vice President, Chief Financial Officer 756.7K 6.87M 845.9K 324.6K 84.0K 8.88M 86.88%
12 2024 Henrik Ancher-Jensen Senior Vice President, President Order Fulfillment and Supply Chain 683.9K 4.32M 571.6K 292.6K 14.3K 5.88M 83.15%
13 2024 Dominique Grau Senior Vice President, Chief Human Resources Officer 610.5K 3.91M 468.7K 175.4K 41.2K 5.20M 84.13%
14 2024 Simon May Senior Vice President, Agilent President Life Sciences and Diagnostics Market Group 276.9K 500.0K 2.26M 564.8K 92.1K 13.8K 3.71M 76.21%
15 2024 Simon May Senior Vice President, President Diagnostics and Genomics Group 276.9K 500.0K 2.26M 564.8K 92.1K 13.8K 3.71M 76.21%
16 2023 Michael R. McMullen Former Chief Executive Officer 1.32M 11.33M 2.78M 514.6K 84.0K 16.02M 88.05%
17 2023 Michael R. McMullen Chief Executive Officer 1.32M 11.33M 2.78M 514.6K 84.0K 16.02M 88.05%
18 2023 Robert McMahon Senior Vice President, Chief Financial Officer 726.8K 3.00M 735.9K 259.6K 89.0K 4.81M 77.64%
19 2023 Robert McMahon Former Senior Vice President; Former Chief Financial Officer 726.8K 3.00M 735.9K 259.6K 89.0K 4.81M 77.64%
20 2023 Henrik Ancher-Jensen Senior Vice President, President Order Fulfillment and Supply Chain 673.4K 1.93M 474.2K 240.0K 14.0K 3.33M 72.18%
21 2023 Sam Raha Senior Vice President, President Diagnostics and Genomics Group 631.2K 1.93M 474.2K 204.4K 41.1K 3.28M 73.30%
22 2023 Padraig McDonnell Senior Vice President, President Agilent Cross Lab Group 606.2K 1.78M 436.1K 316.4K 137.1K 3.27M 67.62%
23 2023 Padraig McDonnell President; Chief Executive Officer 606.2K 1.78M 436.1K 316.4K 137.1K 3.27M 67.62%
24 2023 Padraig McDonnell Chief Executive Officer 606.2K 1.78M 436.1K 316.4K 137.1K 3.27M 67.62%
25 2022 Michael R. McMullen Former Chief Executive Officer 1.28M 10.51M 2.48M 2.30M 81.6K 16.65M 78.02%
26 2022 Michael R. McMullen Chief Executive Officer 1.28M 10.51M 2.48M 2.30M 81.6K 16.65M 78.02%
27 2022 Robert McMahon Senior Vice President, Chief Financial Officer 696.4K 2.63M 620.9K 717.7K 129.3K 4.79M 67.78%
28 2022 Padraig McDonnell Chief Executive Officer 571.2K 1.51M 357.0K 653.0K 70.7K 4.79M 38.98%
29 2022 Henrik Ancher-Jensen Senior Vice President, President Order Fulfillment and Supply Chain 605.0K 2.57M 576.2K 676.7K 23.6K 4.46M 70.71%
30 2022 Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group 647.4K 2.10M 496.7K 797.5K 17.3K 4.06M 63.99%
31 2022 Sam Raha Senior Vice President, President Diagnostics and Genomics Group 596.4K 1.79M 424.3K 504.4K 39.3K 3.36M 66.06%
32 2022 Padraig McDonnell Senior Vice President, President Agilent Cross Lab Group 571.2K 1.51M 357.0K 653.0K 70.7K 3.16M 59.05%
33 2021 Michael R. McMullen Chief Executive Officer 1.28M 9.17M 2.30M 3.15M 77.5K 15.97M 71.77%
34 2021 Robert McMahon Senior Vice President, Chief Financial Officer 663.5K 2.29M 573.8K 1.01M 176.2K 4.71M 60.81%
35 2021 Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group 625.0K 1.81M 453.8K 897.6K 13.7K 3.80M 59.60%
36 2021 Sam Raha Senior Vice President, President Diagnostics and Genomics Group 563.5K 1.54M 386.0K 738.5K 33.5K 3.26M 59.07%
37 2021 Padraig McDonnell Senior Vice President, President Cross-Lab Group 495.0K 1.25M 313.0K 686.7K 499.5K 3.24M 48.17%
38 2021 Padraig McDonnell Senior Vice President, President Agilent Cross Lab Group 495.0K 1.25M 313.0K 686.7K 499.5K 3.24M 48.17%
39 2020 Michael R. McMullen Chief Executive Officer 1.17M 11.19M 1.15M 95.1K 13.61M 82.22%
40 2020 Robert McMahon Senior Vice President, Chief Financial Officer 638.3K 2.61M 359.9K 52.3K 3.67M 71.34%
41 2020 Mark Doak Senior Vice President, President Agilent Cross-Lab Group 316.5K 500.0K 2.61M 189.9K 22.4K 3.64M 71.76%
42 2020 Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group 614.9K 2.12M 321.1K 20.3K 3.07M 68.89%
43 2020 Sam Raha Senior Vice President, President Diagnostics and Genomics Group 538.8K 1.67M 224.2K 34.8K 2.47M 67.72%
44 2020 Michael Tang Senior Vice President, General Counsel 561.0K 1.57M 276.2K 33.8K 2.44M 64.30%
45 2019 Michael R. McMullen Chief Executive Officer 1.22M 9.56M 1.58M 161.9K 12.52M 76.36%
46 2019 Robert McMahon Senior Vice President, Chief Financial Officer 610.0K 1.00M 2.22M 483.3K 64.9K 4.38M 50.72%
47 2019 Mark Doak Senior Vice President, President Agilent Cross-Lab Group 597.9K 2.24M 550.3K 40.4K 3.43M 65.34%
48 2019 Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group 597.9K 1.86M 346.8K 93.9K 2.90M 64.15%
49 2019 Michael Tang Senior Vice President, General Counsel 545.8K 1.35M 381.3K 64.4K 2.34M 57.69%
50 2018 Michael R. McMullen Chief Executive Officer 1.17M 8.48M 1.86M 199.8K 11.71M 72.39%
51 2018 Robert McMahon Senior Vice President, Chief Financial Officer 147.9K 2.00M 4.13M 146.8K 155.4K 6.58M 62.78%
52 2018 Didier Hirsch Former Senior Vice President, Chief Financial Officer 648.3K 2.81M 634.4K 81.4K 4.17M 67.31%
53 2018 Mark Doak Senior Vice President, President Cross-Lab Group 570.8K 2.09M 620.4K 42.0K 3.32M 62.87%
54 2018 Mark Doak Senior Vice President, President Agilent Cross-Lab Group 570.8K 2.09M 620.4K 42.0K 3.32M 62.87%
55 2018 Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group 556.3K 1.85M 484.8K 129.1K 3.02M 61.20%
56 2018 Dominique Grau Senior Vice President, Human Resources 470.6K 1.28M 403.0K 62.6K 2.21M 57.69%
57 2017 Michael R. McMullen Chief Executive Officer 1.10M 7.21M 1.58M 209.3K 10.09M 71.41%
58 2017 Didier Hirsch Senior Vice President, Chief Financial Officer 627.5K 2.68M 556.9K 79.9K 3.94M 67.91%
59 2017 Didier Hirsch Former Senior Vice President, Chief Financial Officer 627.5K 2.68M 556.9K 79.9K 3.94M 67.91%
60 2017 Patrick Kaltenbach Senior Vice President, President Life Sciences and Applied Markets Group 532.1K 1.79M 456.2K 770.6K 3.55M 50.41%
61 2017 Mark Doak Senior Vice President, President Cross-Lab Group 520.8K 1.90M 453.8K 51.8K 2.93M 64.91%
62 2017 Mark Doak Senior Vice President, President Agilent Cross-Lab Group 520.8K 1.90M 453.8K 51.8K 2.93M 64.91%
63 2017 Jacob Thaysen Senior Vice President, President Diagnostics and Genomics Group 495.0K 1.34M 356.6K 211.2K 2.40M 55.73%
64 2017 Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group 495.0K 1.34M 356.6K 211.2K 2.40M 55.73%
65 2016 Michael R. McMullen Chief Executive Officer 1.04M 6.34M 1.34M 193.3K 8.91M 71.13%
66 2016 Patrick Kaltenbach Senior Vice President, President Life Sciences and Applied Markets Group 488.0K 1.48M 418.1K 2.01M 4.39M 33.67%
67 2016 Didier Hirsch Senior Vice President, Chief Financial Officer 600.0K 2.75M 494.1K 90.5K 3.93M 69.88%
68 2016 Didier Hirsch Former Senior Vice President, Chief Financial Officer 600.0K 2.75M 494.1K 90.5K 3.93M 69.88%
69 2016 Jacob Thaysen Senior Vice President, President Diagnostics and Genomics Group 436.7K 845.5K 510.8K 1.02M 2.81M 30.05%
70 2016 Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group 436.7K 845.5K 510.8K 1.02M 2.81M 30.05%
71 2016 Mark Doak Senior Vice President, President Cross-Labs Group 470.8K 1.64M 476.9K 54.4K 2.64M 62.04%
72 2016 Mark Doak Senior Vice President, President Cross-Lab Group 470.8K 1.64M 476.9K 54.4K 2.64M 62.04%
73 2015 Michael R. McMullen President Chief Executive Officer 845.8K 2.52M 2.43M 1.11M 296.3K 7.21M 68.74%
74 2015 Michael R. McMullen Chief Executive Officer 845.8K 2.52M 2.43M 1.11M 296.3K 7.21M 68.74%
75 2015 William P. Sullivan Former President and Chief Executive Officer 630.0K 3.06M 1.95M 894.3K 28.5K 6.47M 77.36%
76 2015 Didier Hirsch Senior Vice President, Chief Financial Officer 600.0K 1.05M 1.00M 516.4K 129.7K 3.30M 62.20%
77 2015 Patrick Kaltenbach Senior Vice President, President Life Sciences and Applied Markets Group 407.3K 505.1K 481.3K 311.7K 945.7K 2.65M 37.21%
78 2015 Henrik Ancher-Jensen Senior Vice President, President Order Fulfillment and Supply Chain 398.9K 274.7K 262.3K 1.17M 153.0K 2.26M 23.73%
79 2015 Mark Doak Senior Vice President, President Cross-Lab Group 422.9K 549.5K 524.7K 421.7K 46.3K 1.97M 54.66%
80 2015 Mark Doak Senior Vice President, President Cross-Labs Group 422.9K 549.5K 524.7K 421.7K 46.3K 1.97M 54.66%
81 2014 William P. Sullivan Chief Executive Officer 1.05M 6.63M 1.63M 31.8K 13.91M 47.67%
82 2014 William P. Sullivan Former President and Chief Executive Officer 1.05M 6.63M 4.57M 1.63M 31.8K 13.91M 80.50%
83 2014 Ronald S. Nersesian Executive Vice President and Keysight 795.8K 2.11M 917.2K 31.0K 6.26M 33.70%
84 2014 Michael R. McMullen President and Chief Operating Officer 606.3K 2.33M 467.2K 39.1K 4.53M 51.48%
85 2014 Michael R. McMullen President Chief Executive Officer 606.3K 2.33M 994.4K 467.2K 130.8K 4.53M 73.42%
86 2014 Michael R. McMullen Chief Executive Officer 606.3K 2.33M 994.4K 467.2K 130.8K 4.53M 73.42%
87 2014 Didier Hirsch Senior Vice President, Chief Financial Officer 600.0K 1.04M 1.05M 633.4K 127.4K 3.45M 60.60%
88 2014 Didier Hirsch Senior Vice President, Chief Financial Officer 600.0K 1.04M 633.4K 16.3K 3.45M 30.25%
89 2014 Marie Oh Huber 525.0K 1.01M 495.0K 28.9K 2.91M 34.67%
90 2013 William P. Sullivan Chief Executive Officer 1.05M 3.79M 1.23M 30.7K 10.24M 37.03%
91 2013 William P. Sullivan President and Chief Executive Officer 1.05M 3.79M 1.23M 30.7K 10.24M 37.03%
92 2013 William P. Sullivan Former President and Chief Executive Officer 1.05M 3.79M 4.14M 1.23M 30.7K 10.24M 77.49%
93 2013 Ronald S. Nersesian Executive Vice President and Keysight 741.7K 1.56M 585.2K 27.9K 4.76M 32.79%
94 2013 Ronald S. Nersesian Executive Vice President and President and Chief 741.7K 1.56M 585.2K 27.9K 4.76M 32.79%
95 2013 Nicolas Roelofs Former Senior Vice President, Life Sciences 550.0K 668.8K 452.2K 1.85M 4.34M 15.42%
96 2013 Didier Hirsch Senior Vice President, Chief Financial Officer 597.9K 869.5K 382.2K 21.7K 2.93M 29.65%
97 2013 Didier Hirsch Senior Vice President, Chief Financial Officer 597.9K 869.5K 950.0K 382.2K 132.6K 2.93M 62.05%
98 2013 Lars Holmkvist 938.6K 891.7K 776.9K 286.8K 2.89M 30.81%
99 2013 Michael R. McMullen Senior Vice President, Chemical Analysis Group 575.0K 802.6K 465.7K 30.1K 2.86M 28.09%
100 2013 Michael R. McMullen President and Chief Operating Officer 575.0K 802.6K 465.7K 30.1K 2.86M 28.09%
101 2013 Michael R. McMullen President Chief Executive Officer 575.0K 802.6K 877.0K 465.7K 136.6K 2.86M 58.79%
102 2012 William P. Sullivan President and Chief Executive Officer 990.0K 3.86M 1.25M 30.9K 10.14M 38.08%
103 2012 William P. Sullivan Chief Executive Officer 990.0K 3.86M 1.25M 30.9K 10.14M 38.08%
104 2012 Ronald S. Nersesian Executive Vice President and Chief Operating 641.7K 1.48M 518.9K 26.9K 4.33M 34.26%
105 2012 Ronald S. Nersesian Executive Vice President and President and Chief 641.7K 1.48M 518.9K 26.9K 4.33M 34.26%
106 2012 Ronald S. Nersesian Executive Vice President and Keysight 641.7K 1.48M 518.9K 26.9K 4.33M 34.26%
107 2012 Nicolas Roelofs Former Senior Vice President, Life Sciences 545.8K 1.72M 413.5K 209.2K 3.80M 45.35%
108 2012 Nicolas H. Roelofs Senior Vice President, Life Sciences Group 545.8K 1.72M 413.5K 209.2K 3.80M 45.35%
109 2012 Michael R. McMullen President and Chief Operating Officer 570.8K 1.77M 443.8K 31.0K 3.80M 46.66%
110 2012 Michael R. McMullen Senior Vice President, Chemical Analysis Group 570.8K 1.77M 443.8K 31.0K 3.80M 46.66%
111 2012 Didier Hirsch Senior Vice President, Chief Financial Officer 570.8K 890.6K 471.2K 16.0K 2.98M 29.89%
112 2011 William P. Sullivan President and Chief Executive Officer 990.0K 3.52M 1.92M 30.2K 10.25M 34.35%
113 2011 Ronald S. Nersesian Executive Vice President and Chief Operating 545.8K 1.76M 740.3K 26.0K 4.31M 40.85%
114 2011 Ronald S. Nersesian Executive Vice President and President and Chief 545.8K 1.76M 740.3K 26.0K 4.31M 40.85%
115 2011 Ronald S. Nersesian Executive Vice President and Chief Operating Officer 545.8K 1.76M 740.3K 26.0K 4.31M 40.85%
116 2011 Michael R. McMullen Senior Vice President, Chemical Analysis Group 519.6K 1.51M 387.5K 29.6K 3.41M 44.28%
117 2011 Nicolas Roelofs Former Senior Vice President, Life Sciences 493.8K 1.41M 394.9K 10.7K 3.14M 44.83%
118 2011 Nicolas Roelofs Senior Vice President, Life Sciences Group 493.8K 1.41M 394.9K 10.7K 3.14M 44.83%
119 2011 Nicolas H. Roelofs Senior Vice President, Life Sciences Group 493.8K 1.41M 394.9K 10.7K 3.14M 44.83%
120 2011 Didier Hirsch Senior Vice President, Chief Financial Officer 520.8K 1.02M 556.8K 13.6K 3.02M 33.75%
121 2011 Didier Hirsch Senior Vice President, Chief Financial Officer 520.8K 1.02M 556.8K 13.6K 3.01M 33.80%
122 2010 William P. Sullivan President and Chief Executive Officer 990.0K 3.40M 2.54M 29.9K 10.44M 32.51%
123 2010 Ronald S. Nersesian Executive Vice President and Chief Operating 497.1K 1.08M 712.5K 25.2K 3.51M 30.60%
124 2010 Ronald S. Nersesian Executive Vice President and Chief Operating Officer 497.1K 1.08M 712.5K 25.2K 3.51M 30.60%
125 2010 Ronald S. Nersesian Senior Vice President, Electronic Measurement 497.1K 1.08M 712.5K 25.2K 3.51M 30.60%
126 2010 Adrian Dillon Former Executive Vice President, Finance and 350.0K 1.19M 446.2K 18.1K 3.28M 36.23%
127 2010 Michael R. McMullen Senior Vice President, Chemical Analysis Group 457.1K 905.3K 557.7K 40.7K 2.99M 30.27%
128 2010 Didier Hirsch Senior Vice President, Chief Financial Officer 366.2K 636.4K 456.4K 238.9K 2.42M 26.26%
129 2010 Nicolas Roelofs Senior Vice President, Life Sciences Group 425.0K 679.0K 446.5K 11.0K 2.35M 28.86%
130 2010 Nicolas H. Roelofs Senior Vice President, Life Sciences Group 425.0K 679.0K 446.5K 11.0K 2.35M 28.86%
131 2010 Didier Hirsch Senior Vice President, Chief Financial Officer 366.2K 636.4K 456.4K 71.7K 2.26M 28.20%
132 2009 William P. Sullivan President and Chief Executive Officer 907.5K 2.72M 949.6K 28.3K 7.57M 35.89%
133 2009 Adrian T. Dillon Executive Vice President, Finance and 641.7K 1.39M 407.7K 25.4K 3.74M 37.25%
134 2009 Adrian Dillon Former Executive Vice President, Finance and 641.7K 1.04M 407.7K 25.4K 3.24M 32.16%
135 2009 D. Craig Nordlund Former Senior Vice President, General 389.6K 362.3K 203.8K 1.55M 2.86M 12.69%
136 2009 Ronald S. Nersesian Senior Vice President, Electronic Measurement 413.1K 931.9K 271.6K 25.1K 2.33M 39.92%
137 2009 Ronald S. Nersesian Executive Vice President and Chief Operating Officer 413.1K 931.9K 271.6K 25.1K 2.33M 39.92%
138 2009 Michael R. McMullen Senior Vice President, Chemical Analysis Group 339.1K 754.4K 254.6K 107.5K 2.04M 36.98%
139 2009 Ronald S. Nersesian Senior Vice President, 413.1K 588.8K 271.6K 25.1K 1.77M 33.21%
140 2009 Nicolas Roelofs Senior Vice President, Life Sciences Group 339.1K 641.2K 250.9K 22.2K 1.61M 39.72%
141 2009 Michael R. McMullen Senior Vice President, Chemical Analysis Group 334.6K 444.0K 287.8K 254.6K 107.5K 1.60M 45.75%
142 2009 Nicolas Roelofs Senior Vice President, Life Sciences Group 334.6K 558.0K 267.3K 250.9K 22.2K 1.49M 55.42%
143 2008 William P. Sullivan President and Chief 986.7K 3.74M 1.31M 28.5K 9.17M 40.76%
144 2008 William P. Sullivan President and Chief Executive Officer 986.7K 3.74M 1.31M 28.5K 9.17M 40.76%
145 2008 Adrian Dillon Former Executive Vice President, Finance and 700.0K 1.56M 627.8K 24.1K 4.17M 37.47%
146 2008 Adrian T. Dillon Executive Vice President, Finance and 700.0K 1.64M 627.8K 24.1K 4.00M 40.95%
147 2008 Adrian T. Dillon Executive Vice President, 700.0K 1.64M 627.8K 24.1K 4.00M 40.95%
148 2008 Jean Halloran Senior Vice President, 400.0K 631.7K 295.4K 23.2K 1.92M 32.82%
149 2008 Ronald S. Nersesian Senior Vice President, Electronic Measurement 397.9K 679.3K 239.1K 24.5K 1.92M 35.47%
150 2008 D. Craig Nordlund Former Senior Vice President, General 425.0K 543.4K 313.9K 22.6K 1.70M 31.98%
151 2008 D. Craig Nordlund Senior Vice President, 425.0K 543.4K 313.9K 22.6K 1.70M 31.98%
152 2008 Ronald S. Nersesian Senior Vice President, Electronic Measurement 397.9K 469.6K 267.0K 239.1K 24.5K 1.48M 49.86%
153 2008 Ronald S. Nersesian Senior Vice President, 397.9K 469.6K 239.1K 24.5K 1.48M 31.78%
154 2007 William P. Sullivan President and Chief Executive Officer 946.9K 650.00 10.26M 2.74M 618.8K 43.4K 15.01M 86.58%
155 2007 William P. Sullivan President and Chief Executive Officer 946.9K 650.00 10.26M 618.8K 43.4K 15.01M 68.34%
156 2007 William P. Sullivan President and Chief 946.9K 650.00 10.26M 618.8K 43.4K 15.01M 68.34%
157 2007 Patrick J. Byrne Former Senior Vice President and President, Electronics Management Group 639.9K 3.99M 2.06M 208.1K 1.22M 8.33M 72.56%
158 2007 Adrian T. Dillon Executive Vice President, Finance and Administration and Chief Financial Officer 700.0K 525.1K 4.15M 700.1K 323.0K 544.4K 7.07M 68.68%
159 2007 Adrian T. Dillon Executive Vice President, 700.0K 525.1K 4.15M 323.0K 544.4K 7.07M 58.77%
160 2007 Adrian T. Dillon Executive Vice President, Finance and 700.0K 525.1K 4.15M 323.0K 544.4K 7.07M 58.77%
161 2007 Christopher van Ingen Former Senior Vice President and President, Life Sciences and Chemical Analysis Group 450.0K 4.18M 896.2K 421.2K 34.6K 6.11M 83.01%
162 2007 Jean Halloran Senior Vice President, 400.0K 2.07M 141.1K 34.9K 3.38M 61.34%
163 2007 Jean Halloran Senior Vice President, Human Resources 400.0K 2.07M 669.8K 141.1K 34.9K 3.38M 81.15%
164 2007 D. Craig Nordlund Senior Vice President, General Counsel and Secretary 425.0K 650.00 1.73M 348.3K 150.0K 35.4K 2.69M 77.34%
165 2007 D. Craig Nordlund Senior Vice President, 425.0K 650.00 1.73M 150.0K 35.4K 2.69M 64.38%
166 2007 D. Craig Nordlund Former Senior Vice President, General 425.0K 650.00 1.73M 150.0K 35.4K 2.69M 64.38%
167 2006 William P. Sullivan President and Chief Executive Officer 906.2K 1.14M 213.6K 8.8K 2.06M 10.39%
168 2006 Adrian T. Dillon Executive Vice President, Finance and Administration, Chief Financial Officer 687.5K 588.2K 108.0K 8.8K 1.28M 8.41%
169 2006 Patrick J. Byrne Senior Vice President, Electronics Measurement Group 472.5K 373.3K 94.5K 8.8K 854.6K 11.06%
170 2006 D. Craig Nordlund Senior Vice President, General Counsel and Secretary 425.0K 247.6K 33.2K 8.8K 681.4K 4.87%
171 2006 Christopher van Ingen Senior Vice President, Life Science and Chemical Analysis 437.5K 227.8K 85.0K 8.8K 674.1K 12.61%
172 2005 Edward W. Barnholt Former President and Chief Executive Officer 1.00M 1.31M 160.0K 8.4K 2.32M 6.89%
173 2005 William P. Sullivan President and Chief Executive Officer 783.3K 773.1K 149.0K 8.4K 1.56M 9.52%
174 2005 Adrian T. Dillon Executive Vice President, Finance and Administration, Chief Financial Officer 650.0K 459.6K 80.0K 8.4K 1.12M 7.16%
175 2005 Thomas E. White Senior Vice President, Operations Support Systems Group 503.0K 270.0K 32.0K 773.0K 4.14%
176 2005 D. Craig Nordlund Senior Vice President, General Counsel and Secretary 425.0K 257.6K 28.5K 8.4K 691.0K 4.12%
177 2005 Jean Halloran Senior Vice President, Human Resources 400.0K 242.4K 25.5K 8.4K 650.8K 3.92%
178 2005 Christopher van Ingen Senior Vice President, Life Science and Chemical Analysis 400.0K 241.3K 73.5K 8.4K 649.7K 11.31%
179 2005 Patrick J. Byrne Senior Vice President, Electronics Measurement Group 379.3K 249.8K 48.0K 8.4K 637.4K 7.53%
180 2004 Edward W. Barnholt Former President and Chief Executive Officer 1.00M 1.50M 154.0K 8.2K 2.51M 6.13%
181 2004 Edward W. Barnholt Chief Executive Officer 1.00M 1.50M 154.0K 8.2K 2.51M 6.13%
182 2004 William P. Sullivan Executive Vice President Chief Operating Officer 637.5K 601.6K 85.0K 8.2K 1.25M 6.81%
183 2004 William P. Sullivan President and Chief Executive Officer 637.5K 601.6K 85.0K 8.2K 1.25M 6.81%
184 2004 Adrian T. Dillon Executive Vice President, Finance and Administration, Chief Financial Officer 650.0K 526.4K 54.0K 8.2K 1.18M 4.56%
185 2004 Adrian Dillon Executive Vice President Chief Financial Officer 650.0K 526.4K 54.0K 8.2K 1.18M 4.56%
186 2004 Young K. Sohn Senior Vice President Semiconductor Products 425.0K 311.5K 8.2K 744.7K 0.00%
187 2004 Christopher van Ingen Senior Vice President, Life Science and Chemical Analysis 396.3K 333.1K 40.0K 8.2K 737.6K 5.42%
188 2004 Chris van Ingen Senior Vice President Life Science and Chemical Analysis 396.3K 333.1K 40.0K 8.2K 737.6K 5.42%
189 2004 Thomas E. White Senior Vice President, Operations Support Systems Group 455.0K 265.9K 29.0K 720.9K 4.02%
190 2004 D. Craig Nordlund Senior Vice President, General Counsel and Secretary 425.0K 245.8K 23.0K 8.2K 679.0K 3.39%
191 2004 Jean Halloran Senior Vice President, Human Resources 400.0K 231.4K 23.0K 8.2K 639.6K 3.60%
192 2004 Patrick J. Byrne Senior Vice President, Electronics Measurement Group 347.0K 189.3K 75.0K 8.2K 544.5K 13.77%
193 2003 Edward W. Barnholt Chairman of the Board, President and Chief Executive Officer 1.00M 333.5K 600.0K 8.0K 1.34M 44.73%
194 2003 Edward W. Barnholt Former President and Chief Executive Officer 1.00M 333.5K 600.0K 8.0K 1.34M 44.73%
195 2003 Edward W. Barnholt Chief Executive Officer 1.00M 333.5K 600.0K 8.0K 1.34M 44.73%
196 2003 Young K. Sohn Senior Vice President Semiconductor Products 92.7K 1.24M 175.0K 1.2K 1.33M 106.09%
197 2003 Adrian T. Dillon Executive Vice President, Finance and Administration, Chief Financial Officer 650.0K 116.7K 250.0K 8.0K 774.7K 32.27%
198 2003 Adrian T. Dillon Executive Vice President, Chief Financial Officer 650.0K 116.7K 250.0K 8.0K 774.7K 32.27%
199 2003 Adrian Dillon Executive Vice President Chief Financial Officer 650.0K 116.7K 250.0K 8.0K 774.7K 32.27%
200 2003 William P. Sullivan President and Chief Executive Officer 600.0K 107.7K 250.0K 8.0K 715.7K 34.93%
201 2003 William P. Sullivan Executive Vice President Chief Operating Officer 600.0K 107.7K 250.0K 8.0K 715.7K 34.93%
202 2003 William P. Sullivan Executive Vice President, Chief Operating Officer 600.0K 107.7K 250.0K 8.0K 715.7K 34.93%
203 2003 Byron J. Anderson Senior Vice President, Electronic Products and Solutions 525.0K 16.2K 125.0K 8.0K 549.2K 22.76%
204 2003 Chris van Ingen Senior Vice President Life Science and Chemical Analysis 374.8K 121.5K 125.0K 8.0K 504.3K 24.79%
205 2003 Chris van Ingen Senior Vice President, Life Science and Chemical Analysis 374.8K 121.5K 125.0K 8.0K 504.3K 24.79%
206 2003 D. Craig Nordlund Senior Vice President, General Counsel and Secretary 425.0K 54.5K 100.0K 8.0K 487.5K 20.51%
207 2003 Jean Halloran Senior Vice President, Human Resources 400.0K 51.3K 100.0K 8.0K 459.3K 21.77%
208 2003 Thomas E. White Senior Vice President, Operations Support Systems Group 430.6K 17.9K 70.0K 448.5K 15.61%
209 2002 Adrian T. Dillon Executive Vice President, Chief Financial Officer 552.5K 650.0K 1.37M 200.0K 5.1K 2.57M 60.83%
210 2002 Adrian T. Dillon Executive Vice President, Chief Financial Officer 552.5K 650.0K 1.37M 5.1K 2.57M 53.06%
211 2002 Adrian Dillon Executive Vice President Chief Financial Officer 552.5K 650.0K 1.37M 200.0K 5.1K 2.57M 60.83%
212 2002 Edward W. Barnholt Chief Executive Officer 925.0K 750.0K 8.0K 933.0K 80.39%
213 2002 Edward W. Barnholt Chairman of the Board, President and Chief 925.0K 8.0K 933.0K 0.00%
214 2002 Edward W. Barnholt Chairman of the Board, President and Chief Executive Officer 925.0K 750.0K 8.0K 933.0K 80.39%
215 2002 John E. Scruggs Senior Vice President, Automated Test 462.5K 135.6K 8.0K 606.1K 0.00%
216 2002 William P. Sullivan Executive Vice President, Chief Operating Officer 532.5K 300.0K 3.6K 536.1K 55.96%
217 2002 William P. Sullivan Executive Vice President Chief Operating Officer 532.5K 300.0K 3.6K 536.1K 55.96%
218 2002 William P. Sullivan Executive Vice President, Chief Operating Officer 532.5K 3.6K 536.1K 0.00%
219 2002 Byron J. Anderson Senior Vice President, Electronic Products and 485.6K 8.0K 493.6K 0.00%
220 2002 Byron J. Anderson Senior Vice President, Electronic Products and Solutions 485.6K 175.0K 8.0K 493.6K 35.45%
221 2002 Jack P. Trautman Senior Vice President, Automated Test 367.4K 67.1K 472.00 435.0K 0.00%
222 2002 D. Craig Nordlund Senior Vice President, General Counsel and Secretary 393.1K 100.0K 8.0K 401.1K 24.93%
223 2002 Chris van Ingen Senior Vice President, Life Science and Chemical Analysis 323.8K 42.9K 125.0K 8.0K 374.6K 33.37%
224 2002 Chris van Ingen Senior Vice President Life Science and Chemical Analysis 323.8K 42.9K 125.0K 8.0K 374.6K 33.37%
225 2002 Young K. Sohn Senior Vice President Semiconductor Products
226 2001 Edward W. Barnholt President and Chief Executive Officer 941.7K 6.8K 948.5K 0.00%
227 2001 Edward W. Barnholt Chairman of the Board, President and Chief 941.7K 6.8K 948.5K 0.00%
228 2001 Edward W. Barnholt Chairman of the Board, President and Chief Executive Officer 941.7K 500.0K 6.8K 948.5K 52.72%
229 2001 Alain A. Couder Executive Vice President and Chief Operating Officer 668.8K 5.1K 673.9K 0.00%
230 2001 Byron J. Anderson Senior Vice President, Electronic Products and Solutions 488.1K 75.0K 6.8K 494.9K 15.15%
231 2001 Byron J. Anderson Senior Vice President, Electronic Products and 488.1K 6.8K 494.9K 0.00%
232 2001 Byron Anderson Senior Vice President, Electronic Products and Solutions 488.1K 6.8K 494.9K 0.00%
233 2001 William P. Sullivan Executive Vice President, Chief Operating Officer 473.1K 200.0K 6.8K 479.9K 41.67%
234 2001 William P. Sullivan Senior Vice President, Semiconductor Products 473.1K 6.8K 479.9K 0.00%
235 2001 William P. Sullivan Executive Vice President, Chief Operating Officer 473.1K 6.8K 479.9K 0.00%
236 2001 John E. Scruggs Senior Vice President, Automated Test 463.3K 6.8K 470.1K 0.00%
237 2001 D. Craig Nordlund Senior Vice President, General Counsel and Secretary 392.0K 150.0K 6.8K 398.8K 37.62%
238 2001 Chris van Ingen Senior Vice President, Life Science and Chemical Analysis 329.6K 125.0K 6.8K 336.4K 37.16%
239 2001 Adrian T. Dillon Executive Vice President, Chief Financial Officer
240 2001 Jack P. Trautman Senior Vice President, Automated Test
241 2001 Adrian T. Dillon Executive Vice President, Chief Financial Officer
242 2000 Edward W. Barnholt Chairman of the Board, President and Chief 1.00M 660.0K 46.9K 6.8K 1.71M 2.74%
243 2000 Edward W. Barnholt President and Chief Executive Officer 1.00M 660.0K 46.9K 6.8K 1.71M 2.74%
244 2000 John E. Scruggs Senior Vice President, Automated Test 470.0K 243.9K 19.8K 6.8K 740.5K 2.67%
245 2000 Byron J. Anderson Senior Vice President, Electronic Products and 500.0K 173.7K 21.3K 6.8K 701.8K 3.04%
246 2000 Byron Anderson Senior Vice President, Electronic Products and Solutions 500.0K 173.7K 21.3K 6.8K 701.8K 3.04%
247 2000 William P. Sullivan Executive Vice President, Chief Operating Officer 440.0K 205.3K 7.3K 652.6K 0.00%
248 2000 William P. Sullivan Senior Vice President, Semiconductor Products 440.0K 205.3K 7.3K 652.6K 0.00%
249 2000 Alain A. Couder Executive Vice President and Chief Operating Officer 427.3K 85.5K 5.1K 517.9K 0.00%
250 2000 Adrian T. Dillon Executive Vice President, Chief Financial Officer
251 2000 Jack P. Trautman Senior Vice President, Automated Test
252 1999 Edward W. Barnholt President and Chief Executive Officer 920.6K 474.7K 409.1K 313.9K 2.12M 19.31%
253 1999 William P. Sullivan Senior Vice President, Semiconductor Products 408.4K 174.3K 177.6K 30.7K 791.0K 22.45%
254 1999 John E. Scruggs Senior Vice President, Automated Test 415.2K 193.4K 21.2K 80.1K 709.8K 2.98%
255 1999 Byron Anderson Senior Vice President, Electronic Products and Solutions 425.0K 135.7K 22.9K 109.5K 693.1K 3.31%
256 1999 Alain A. Couder Executive Vice President and Chief Operating Officer
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-02-06 DEFA14A
2026-02-06 DEF 14A
2026-01-23 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-27 8-K
2026-05-21 4
2026-05-12 4
2026-05-08 3
2026-05-04 8-K
2026-04-29 SC 13G
2026-04-28 SC 13G
2026-04-06 8-K/A
2026-04-03 8-K
2026-04-02 4

Executive team

NameTitleCompensationGender
Padraig McDonnell Chief Executive Officer, President & Director 3M male
Simon May Senior VP and President of Life Sciences & Diagnostics Markets Group 2M
Bret DiMarco Senior VP & Secretary 1M male
Angelica Riemann Senior VP & President of Agilent CrossLab Group 1M female
Rodney Gonsalves Principal Accounting Officer, Vice President & Corporate Controller 832.1K male
Adam S. Elinoff Senior Vice President, Chief Financial Officer & Principal Financial Officer male
Tejas Rajeev Savant Vice President of Investor Relations male
August Specht Senior Vice President & Chief Technology Officer male
Frederick Schwarz Senior VP, Chief Strategy & Corporate Development Officer male
Meghan A. Henson Senior Vice President & Chief Human Resources Officer female
Michael Buckner Senior VP & Chief Legal Officer male
ESG Rating
B+
MEDICAL - DIAGNOSTICS & RESEARCH
Rank: 4 out of 65
2010
E (Environmental)
73.1 / 61.3
Company / Sector avg.
S (Social)
69.5 / 65.4
Company / Sector avg.
G (Governance)
61.9 / 64.9
Company / Sector avg.
ESG Total
68.2 / 63.8
Company / Sector avg.
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
Transaction Date Disclosed Senator State Owner Type Amount Link
2024-05-03 2024-06-14 Tommy Tuberville AL Joint Sale (Full) $1,001 - $15,000
2024-04-05 2024-05-15 Tommy Tuberville AL Joint Purchase $1,001 - $15,000
2023-10-16 2023-11-16 Tommy Tuberville AL Joint Sale (Partial) $1,001 - $15,000
2023-04-03 2023-05-12 Tommy Tuberville AL Joint Purchase $1,001 - $15,000
2022-04-03 2023-05-11 Tommy Tuberville AL Joint Purchase $1,001 - $15,000
2016-09-13 2016-10-20 James Inhofe OK Self Sale (Full) $50,001 - $100,000
2015-08-24 2015-09-10 James Inhofe OK Self Purchase $15,001 - $50,000
2015-02-24 2015-03-17 Sheldon Whitehouse RI Self Sale (Full) $1,001 - $15,000
2014-10-02 2014-10-28 Sheldon Whitehouse RI Self Purchase $1,001 - $15,000
House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2025-09-29 2025-10-03 Ro Khanna CA17 Purchase $1,001 - $15,000
2025-07-16 2025-08-13 Lisa McClain MI09 Spouse Sale (Full) $1,001 - $15,000
2025-07-16 2025-08-14 Lisa McClain MI09 Spouse Sale $1,001 - $15,000
2025-06-17 2025-08-14 Lisa McClain MI09 Spouse Purchase $1,001 - $15,000
2025-05-15 2025-06-02 Rob Bresnahan PA08 Purchase $1,001 - $15,000
2025-05-12 2025-06-23 Jefferson Shreve IN06 Sale $15,001 - $50,000
2025-04-17 2025-05-09 Jefferson Shreve IN06 Purchase $15,001 - $50,000
2025-04-08 2025-04-29 Rob Bresnahan PA08 Sale $1,001 - $15,000
2025-04-01 2025-05-15 Julie Johnson TX32 Joint Sale $1,001 - $15,000
2025-03-13 2025-04-14 Jefferson Shreve IN06 Sale $15,001 - $50,000
2025-03-03 2025-04-15 Julie Johnson TX32 Sale $1,001 - $15,000
2024-10-14 2024-11-11 Ro Khanna CA17 Purchase $1,001 - $15,000
2023-11-03 2023-12-06 Ro Khanna CA17 Purchase $1,001 - $15,000
2023-10-31 2023-11-08 Ro Khanna CA17 Spouse Purchase $1,001 - $15,000
2023-10-02 2023-11-08 Ro Khanna CA17 Sale $1,001 - $15,000
2023-06-29 2023-07-11 Ro Khanna CA17 Spouse Sale $15,001 - $50,000
2023-06-26 2023-07-11 Ro Khanna CA17 Purchase $1,001 - $15,000
2023-05-23 2023-06-12 Ro Khanna CA17 Sale $15,001 - $50,000
2022-06-16 2022-07-07 Ro Khanna CA17 Spouse Purchase $15,001 - $50,000
2022-05-10 2022-06-10 Ro Khanna CA17 Purchase $15,001 - $50,000
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits